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ABSTRACT
The development of new multiphoton absorbing materials has attracted the attention of
researchers for the last two decades. The advantages that multiphoton absorbing materials offer,
versus their one-photon absorbing counterparts, rely on the nature of the nonlinearity of the
absorption process, where two photons are absorbed simultaneously offering increased 3D
resolution, deeper penetration, and less photobleaching and photodamage as a result of a more
confined excitation. The applications of efficient two-photon absorbing materials have been
extensively expanding into the fields of photodynamic therapy, microscopy, and optical data
storage. One of the fields where an increased interest in multiphoton absorbing materials has
been most evident is in bioimaging, in particular, when different cellular processes and
organelles need to be studied by fluorescence microscopy. The goal of this research was to
develop efficient two-photon absorption (2PA) compounds to be used in fluorescence
bioimaging, meaning that such compounds need to posses good optical properties, such as high
fluorescence quantum yield, 2PA cross section, and photostability.
In the first chapter of this dissertation, we describe the synthesis and structural
characterization of a new series of fluorescent donor–acceptor and acceptor-acceptor molecules
based on the fluorenyl ring system that incorporated functionalities such as alkynes and
thiophene rings, through efficient Pd-catalyzed Sonogashira and Stille coupling reactions, in
order to increase the length of the conjugation in our systems. These new molecules proved to
have high two-photon absorption (2PA), and the effect of these functionalities on their 2PA cross
section values was evaluated. Finally, their use in two-photon fluorescence microscopy (2PFM)
imaging was demonstrated.
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One of the limitations of the compounds described in Chapter 1 was their poor water
solubility; this issue was addressed in Chapter 2. The use of micelles in drug delivery has been
shown to be an area of increasing interest over the last decade. In the bioimaging field, it is key
to have dye molecules with a high degree of water solubility to enable cells to uptake the dye. By
enclosing a hydrophobic dye in Pluronic® F-127 micelles, we developed a system that facilitates
the use of 2PA molecules (typically hydrophobic) in biological systems for nonlinear
biophotonic applications, specifically to image the lysosomes. Furthermore, we report in this
chapter the efficient microwave-assisted synthesis of the dye used in this study.
In addition, linear photophysical and photochemical parameters, two-photon absorption
(2PA), and superfluorescence properties of the dye studied in Chapter 2, were investigated in
Chapter 3. The steady-state absorption, fluorescence, and excitation anisotropy spectra of this
dye were measured in several organic solvents and aqueous media.
In Chapter 4, we describe the preparation and the use of an efficient and novel twophoton absorbing fluorescent probe conjugated to an antibody that confers selectivity towards the
vascular endothelial growth factor receptor 2 (VEGFR-2) in porcine aortic endothelial cells that
express this receptor (PAE-KDR). It is known that this receptor is overexpressed in certain
cancer processes. Thus, targeting of this receptor will be useful to image the tumor vasculature. It
was observed that when the dye was incubated with cells that do not express the receptor, no
effective binding between the bioconjugate and the cells took place, resulting in very poor, nonspecific fluorescence images by both one and two-photon excitation. On the other hand, when
the dye was incubated with cells that expressed VEGFR-2, efficient imaging of the cells was
obtained, even at very low concentrations (0.4 μM). Moreover, incubation of the bioconjugate
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with tissue facilitated successful imaging of vasculature in mouse embryonic tissue.
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CHAPTER 1. A SERIES OF FLUORENE-BASED TWO-PHOTON
ABSORBING MOLECULES: SYNTHESIS, LINEAR AND NONLINEAR
CHARACTERIZATION, AND BIOIMAGING
Reproduced with permission from: Carolina D. Andrade, Ciceron O. Yanez, Luis
Rodriguez, Kevin D. Belfield, Journal of Organic Chemistry, 2010, 75 (12), 3975-3982.
Copyright 2010 American Chemical Society.
1.1 Abstract

The synthesis, structural, and photophysical characterization of a series of new
fluorescent donor–acceptor and acceptor-acceptor molecules, based on the fluorenyl ring system,
with two-photon absorbing properties is described.

These new compounds exhibited large

Stokes shifts, high fluorescent quantum yields, and, significantly, high two-photon absorption
cross sections, making them well suited for two-photon fluorescence microscopy (2PFM)
imaging. Confocal and two-photon fluorescence microscopy imaging of COS-7 and HCT 116
cells incubated with probe I showed endosomal selectivity, demonstrating the potential of this
class of fluorescent probes in multiphoton fluorescence microscopy.
Keywords: Fluorescent dyes, multiphoton absorption, fluorescence, two-photon,
bioimaging.
1.2 Introduction

The development of multiphoton absorbing materials has attracted the interest of the
scientific community in the last decade due to their potential applications in areas as optical data
storage systems, microscopy imaging, optical limiting materials, and photodynamic therapy. In
one-photon absorption processes, the absorbed light is directly proportional to the incident light
intensity, whereas in two-photon absorption (2PA) processes, the probability of absorbing two
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photons simultaneously is proportional to the square of the incident light intensity.[1] This
nonlinear dependence provides several advantages, including highly confined excitation,
increased 3D resolution (Figure 1-1), and the potential increase of penetration depth in tissue,
important features in fields such as optical data storage,[2-4] 3D microfabrication,[5-7] and
fluorescence microscopy.[1, 8]

Figure 1-1 One-photon (left arrow) vs. two-photon (right arrow) excitation, showing the high 3D
spatially-localized excitation in 2PA in a solution of dye I.

We previously reported a series of fluorescent dyes and photoacid generators that use
fluorene as a core structure.[9-14] This core exhibited high thermal and photochemical stability
making this class of compounds promising in areas such as lasing applications.[15]
Recently, a computational quantum chemical study of numerous fluorene derivatives was
reported in order to predict and rationalize certain 2PA parameters, such as 2PA cross sections
and 2PA wavelength. Though insightful, little comparison and validation of computed results
with experimental data was presented, emphasizing the need to accurately measure 2PA spectra
and cross sections of new compounds.[16]
In the interest of developing more efficient 2PA fluorophores, it is essential to improve
the key photophysical properties such as quantum yield, absorption maxima, and 2PA cross
sections in the tuning range of commercial Ti:sapphire lasers (700-1000 nm). In this work, we
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present the design, synthesis, and photophysical (linear and nonlinear) characterization of a new
series of two-photon absorbing molecules based on a fluorenyl core and demonstration of their
use in in vitro confocal and two-photon fluorescence microscopy (2PFM) bioimaging.
In this approach, a series of dyes were developed with the general structural design
donor-pi-acceptor (D-π-A) and acceptor-pi-acceptor (A-π-A) using benzothiazole moieties as
electron-acceptor groups and diphenylamino groups as electron-donor moieties. To enhance the
solubility of the fluorene core in organic solvents, both protons on the 9-position of fluorene
were substituted by alkyl chains. Functionalities including thiophene and alkynes were
incorporated in order to increase the length of the π -conjugation and to evaluate the effect of
these functionalities on the linear absorption maxima, fluorescence quantum yields, and 2PA
cross sections. The chemical structures of the new fluorescent compounds presented in this paper
are illustrated in Figure 1-2.
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Figure 1-2 Structures of new donor-pi-acceptor (D-π-A) (I and III) and acceptor-pi-acceptor (A-π-A) (II
and IV) fluorenyl derivatives. Benzothiazole moieties were used as acceptor groups while diphenylamino
groups were used as donor moieties. Thiophene groups and alkynes were incorporated to extend the πconjugation.
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For the work described herein, the thiophene ring was chosen as a π electron bridge
because it has a higher degree of aromaticity than other five member rings, e.g., furan, it is stable
towards oxidation, and its chemical reactivity to allow functionalization is higher than that
observed for benzene or furan. Incorporation of these heterocyclic rings in the molecular design
of chromophores has been reported to enhance the optical properties, increasing both the
maximum of absorption (absmax) and the 2PA cross section values, particularly when the
thiophene ring is close to the fluorene core.[17, 18]
One of our goals was to compare this new series of compounds with our previously
prepared and studied probes that contain benzothiazole groups. Thus, the bezothiazole ring
system was used as an electron withdrawing group. Previous studies suggested that compounds
containing this moiety are more robust than analog compounds containing benzoxazole groups.
Moreover, benzothiazole groups are relatively strong electron withdrawing groups, and their
ability to accept charge transferred from a diphenylamino moiety appears to be higher than that
observed for benzoxazolyl containing compounds.[19, 20]
1.3 Results and Discussion

1.3.1 Synthesis of new fluorescent probes
The model 2PA fluorescent probe I was synthesized starting from the transformation of
benzothiazole derivative 1 into tin derivative 2, followed by Pd-catalyzed Stille coupling with
key fluorenyl intermediate 3 was accomplished, as shown in Scheme 1-1, to yield nitrofluorenyl
4 in excellent yield.[19, 21] Reduction of the nitrofluorenyl 4, and subsequent reaction of

resulting amine 5 with iodobenzene under Ullman conditions, generated the D-π-A type
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fluorescent dye I.[19, 22] Stille coupling between dibromofluorene derivative 6 and the tin
thiophene benzothiazole intermediate 2 yielded symmetrical dye II[11, 19, 21] (Scheme 1-1).
Scheme 1-1
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The synthesis of alkyne-containing dyes was achieved by means of successive
Sonogashira coupling.[23] To prepare the asymmetrical compound III, 2-(5-bromothiophen-2yl)benzothiazole 1 was converted into protected alkyne 7 which, after hydrolysis in toluene with
KOH, generated alkyne 8 (Scheme 1-2).[24, 25] Pd-catalyzed Sonogashira coupling between the
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alkyne 8 and key intermediate 3 yielded nitro derivative 9, which was reduced with hydrazine to
produce amine 10 in high yield. Amine 10 was treated with iodobenzene under Ullman
conditions to generate the asymmetrical Dπ-A III (Scheme 1-2). [19, 22]
Scheme 1-2
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The symmetrical intermediate 11 was prepared using Sonogashira coupling between 9,9didecyl-2,7-dibromofluorene 6 and 2-methylbut-3-yn-2-ol.[24, 25] After hydrolysis, the dialkyne
12 was coupled through a second Sonogashira reaction with 1, yielding symmetrical Aπ-A

fluorenyl dye IV (Scheme 1-3).
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Scheme 1-3
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1.3.2 Linear photophysical properties
Table 1-1 summarizes the photophysical properties of the four new fluorescent dyes (IIV). As can be seen in Figure 1-3, all molecules exhibited an intense absorption between 397-

405 nm, fluorescent maximum in the range of 433-452 nm, and significant Stokes shift values in
hexane (see Table 1-1). The new compounds also exhibited high fluorescence quantum yields
(0.86-0.98), while a slight blue shift in the absorption maximum was observed when alkynyl
moieties were incorporated in both symmetrical and asymmetrical derivatives.
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Table 1-1 Photophysical characterization of new fluorene derivatives I, II, III, and IV in hexane.

absmax, nm

emmax, nm

ΔSt, nm

Φ1

εmax.10-3,
M-1.cm-1

I

4031

4521

492

0.860.05

53

II

4051

4461

412

0.980.05

31

III

3981

4441

462

0.920.05

50

IV

3971

4331

362

0.950.05

135

Fluorescence quantum yield measured relative to 9,10-diphenylanthracene in cyclohexane.
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Figure 1-3 Normalized absorption (left) and fluorescence (right) spectra for I, II, III, and IV in hexane.
Absorption and emission spectra were collected at room temperature using hexanes solutions with optical
density of ~0.1 (approximately 10-6 M) without degassing the solutions. Emission was collected by
exciting samples at their λabsmax value.

1.3.3 Nonlinear photophysical properties
Two-photon absorption (2PA) values were determined by the fluorescent method,
measuring the two-photon exited fluorescence of the dyes in the range of 730-860 nm in hexane.
The 2PA cross section measurements were performed with a tunable Ti:sapphire femtosecond
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laser system (220 fs pulse width, 76 MHz repetition rate) pumped by a 10 W diode laser (532
nm) as the excitation source and a spectrofluorimeter with PMT detectors.
The 2PA spectra for this series of compounds are shown in Figure 1-4. Compound I
exhibited a maximum 2PA cross section of ~248 GM at 730 nm which can be attributed to the
tail of the band corresponding to the two-photon allowed S0  S2 transition; a second maximum
of ~217 GM at 800 nm, assigned to S0  S1 2PA forbidden transition, was also observed.
Compound II exhibits a maximum 2PA cross section of ~335 GM at 730 nm. Comparing these
results with our previously reported data for similar molecules that did not contain the thiophene
moiety a significant increase in the 2PA cross section values was observed when the thiophenyl
moiety is introduced in the fluorophore.[9-14]
To observe the effect of the presence of alkynyl triple bonds in the new derivatives,
comparisons of compound I to compound III (D-π-A) and compound II to compound IV (A-πA) were conducted. Compound III exhibited a maximum 2PA cross section of ~563 GM at 730
nm while a second maximum of ~356 GM at 800 nm was observed. Comparing these values to
those obtained for compound I, it can be inferred that incorporating alkynyl triple bonds in these
molecules results in an enhancement in the 2PA cross section for this unsymmetrical compound.
The 2PA cross section value obtained for compound II (~335 GM at 730 nm) can be
compared with the large value obtained for compound IV at the same wavelength (~1093 GM).
A significant increase in the 2PA cross section was observed when the number of alkynyl triple
bonds was doubled.
Since the number of π electrons in these molecules is different, it is also useful to
compare the ratios of 2PA cross section (δ) over the number of π-electrons (Ne) in the
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chromophores (normalized cross section).[18, 26] When comparing I to III, it was observed that
the incorporation of a triple bond in the π system resulted in a two-fold increase in the
normalized cross section value (7 to 14 GM per π electron). Similarly, a three-fold increase of
the normalized cross section was observed when comparing II and IV (9 and 27 GM per π
electron, respectively).
In general, a considerable increase in the value of 2PA cross section was obtained when
thiophene moieties were introduced in both fluorophore archetypes (D-π-A and A-π-A) studied
in this series. In addition, extending the π-conjugation with alkynyl triple bond functionalities
also significantly increased the 2PA for this class of molecules.
I
II
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1000
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Figure 1-4 2PA spectra obtained for compounds I-IV in hexane. Incorporation of thiophene and alkynyl
moieties resulted in an increase in the 2PA cross section values.
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1.3.4 Fluorescence imaging
In order to evaluate the efficiency of these archetypes as fluorophores in 2PFM cell
imaging, fluorene I was incubated in COS-7 and HCT 116 cell lines at different concentrations
and incubation times. Probe I was chosen as model compound due to its relatively constant twophoton absorptivity across a useful NIR wavelength range (750-860 nm for the Ti:sapphire laser,
Figure 1-4) and because it exhibited better solubility in DMSO than the more symmetrical
compounds II and IV (important for cell incubation). Fluorescence micrographs indicated the
distinct localization the probe in well confined areas within the cytosol in both COS-7 and HCT
116 cell lines (Figures 1-5 and 1-6). Probe I was incubated with a commercially available
lysosomal selective dye (Lysotracker Red) and incubated for 10 min, 30 min, 50 min, 1 h 10
min, 1 h 30 min and 1 h 50 min, after incubation the cells were fixed, mounted, and imaged.
Early colocalization with Lysotracker dye suggests a similar uptake mechanism for both the
Lysotracker dye and probe I. However, longer incubation times (50 min and 1 h 50 min)
indicates a difference in the progression of the probe from the endosomal vesicles to the
lysosomes, where the Lysotracker dye reached the lysosomes more quickly than probe I (see
Figure 1-5). The slower progression of probe I may prove useful for the study of late endosomal
processes.
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Figure 1-5 Confocal fluorescence images of COS-7 cells incubated with probe I (20 M, 1 h 50 min) and
Lysotracker Red (100 nM, 1 h 50 min). (A) DIC, one-photon fluorescence image showing (B)
Lysotracker Red (Texas Red filter cube (Ex:562/40; DM: 593; Em:624/40)), (C) probe I (custom made
filter cube (Ex:377/50; DM: 409; Em:525/40)) , and (D) colocalization (overlay of B and C). 10 m scale
bar.

The high contrast and good resolution observed in 2PFM images of HCT 116 cells,
incubated with probe I, support use of the fluorenyl core as an integral part of the fluorescent
probe’s molecular architecture. The excellent linear and nonlinear photophysical properties
points towards their potential as efficient 2PA fluorophores. The 2PFM image, shown in Figure
1-6, where the vesicles (presumably late endosomes) are clearly visualized in both 2D and 3D, is
a testament of the efficacy of the 2PA fluorophore. The potential of these dyes exceeds that of
imaging the endosomes, as further functionalization of the dye can be performed to modulate the
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solubility properties and, more importantly, impart selectivity to other organelles or biomarkers
of interest, aspects of current investigation. The new fluorenyl derivatives provide the basis for
the development of fluorescent probes for 2PFM.

Figure 1-6 Two-photon fluorescence micrograph of HCT 116 cells incubated with probe I (20 M, 1 h
50 min). A) DIC, B) 3D reconstruction from overlaid 2PFM images obtained from a modified laser
scanning confocal microscopy system equipped with a broadband, tunable Ti:sapphire laser (220 fs pulse
width, 76 MHz repetition rate), pumped by a 10 W frequency doubled Nd:YAG laser. (60x objective,
NA= 1.35). Scale: 5 μm grid.

1.4 Experimental Section

1.4.1 Materials and methods
2-(5-Bromothiophen-2-yl)benzothiazole 1, 9,9-didecyl-2-iodo-7-nitro-9H-fluorene 3,
and 2,7-dibromo-9,9-didecyl-9H-fluorene 6 were prepared as described in the literature.[19, 27,
28] All reactions were carried out under N2. All other reagents and solvents were used as
received from commercial suppliers. 1H and
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C NMR spectra were recorded in CDCl3 on a

NMR spectrometer at 500 and 125 MHz, respectively. MALDI MS analyses were performed at
the University of Florida.
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1.4.2 Synthetic procedures and characterization
Synthesis of 2-(5-(tributylstannyl)thiophen-2-yl)benzothiazole (2). At -78 C 2-(5-

bromothiophen-2-yl)benzothiazole 1 (200 mg, 0.67 mmol) was dissolved in dry THF (5 mL). A
solution of n-BuLi in hexanes (0.27 mL, 2.5 M, 0.68 mmol) was added dropwise into the
reaction mixture. After stirring for 1 h, Sn(Bu)3Cl (360 mg, 1.10 mmol) was added and the
mixture was allowed to reach room temperature, and stirred overnight. The mixture was added to
water, extracted with Et2O twice, dried over MgSO4, and purified by column chromatography
using a mixture of hexanes:EtOAc (9:1) as an eluent to yield 240 mg (70%) of viscous oil. 1H
NMR (500 MHz, CDCl3) δ8.02(d, J= 8.2 Hz, 1H, Ph-H), 7.82 (d, J= 8.0 Hz, 1H, Ph-H), 7.74 (d,
J= 3.5 Hz, 1H, Thy-H), 7.43-7.47 (m, 1H, Ph-H), 7.31-7.35 (m, 1H, Ph-H), 7.18 (d, J= 3.5 Hz,
1H, Thy-H), 1.55-1.63 (m, 6H, CH2), 1.31-1.39 (m, 6H, CH2), 1.12-1.19 (m, 6H, CH2), 0.90 (t,
J= 7.34 Hz, 9H, CH3). 13C NMR (125 MHz, CDCl3) δ 161.4, 153.9, 143.5, 142.4, 136.2, 134.7,
129.6, 126.2, 125.1, 122.9, 121.4, 28.9, 27.3, 13.7, 11.0. Anal. Calcd for C23H33NS2Sn: C, 54.56;
H, 6.57; N, 2.77. Found: C, 54.85; H, 6.67; N, 2.86.
Synthesis of 2-(5-(9,9-didecyl-7-nitro-9H-fluoren-2-yl)thiophen-2-yl)benzothiazole

(4).

9,9-Didecyl-2-iodo-7-nitro-9H-fluorene

3

(200

mg,

0.32

mmol),

2-(5-

(tributylstannyl)thiophen-2-yl)benzothiazole 2 (191 mg, 0.38 mmol), and Pd(PPh3)2Cl2 (6 mg,
0.008 mmol) were dissolved in toluene (4 mL). The mixture was heated under reflux for 5 h. The
solvent was removed under reduced pressure and the crude was purified by column
chromatography using a mixture of hexanes:EtOAc (9.5:0.5) as an eluent to yield 222 mg (98%)
of yellow oil that solidified upon standing (m.p. 73.2-74.9 C). 1H NMR (500 MHz, CDCl3) δ
8.28 (dd, J= 8.3 Hz, J= 2.0 Hz, 1H, Ph-H), 8.22 (d, J= 2.0 Hz, 1H, Ph-H), 8.05 (d, J= 8.0 Hz,
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1H, Ph-H), 7.88 (d, J= 7.8 Hz, 1H, Ph-H), 7.79-7.84 (m, 2H, Ph-H), 7.72-7.76 (m, 1H, Ph-H),
7.69 (d, J= 1.4 Hz, 1H, Ph-H), 7.66 (d, J= 3.7 Hz, 1H, Thy-H), 7.48-7.53 (m, 1H, Ph-H), 7.46
(d, J= 3.7 Hz, 1H, Thy-H), 7.37-7.42 (m, 1H, Ph-H), 2.01-2.09 (m, 4H, CH2), 0.99-1.24 (m,
28H, CH2), 0.82 (t, J= 7.0 Hz, 6H, CH3), 0.54-0.69 (m, 4H, CH2). 13C NMR (125 MHz, CDCl3)
δ 161.0, 153.7, 153.4, 152.2, 147.9, 147.2, 146.8, 139.0, 136.6, 134.7, 134.4, 129.5, 126.6, 125.3,
124.40, 124.36, 123.5, 122.0, 121.9, 121.5, 120.4, 120.0, 118.3, 55.9, 40.1, 31.8, 29.8, 29.49,
29.47, 29.24, 29.19, 23.8, 22.6, 14.1. Anal. Calcd for C44H54N2O2S2: C, 74.74; H, 7.70; N, 3.96.
Found: C, 74.97; H, 7.85; N, 3.97.
Synthesis of 7-(5-(benzothiazol-2-yl)thiophen-2-yl)-9,9-didecyl-9H-fluoren-2-amine

(5). 2-(5-(9,9-Didecyl-7-nitro-9H-fluoren-2-yl)thiophen-2-yl)benzothiazole 4 (160 mg, 0.23
mmol) and 10% Pd/C (16 mg) were dissolved in a mixture 1:1 of THF:EtOH (8 mL).
NH2NH2.2H2O (136 mg, 2.7 mmol) was added to the mixture slowly at room temperature, and
then heated to 70 C for 20 h. The mixture was filtered though a silica plug with CH2Cl2, and,
after removing the solvent under reduced pressure, the material was purified by column
chromatography using as a solvent a mixture of hexanes:EtOAc (9:1), to yield 130 mg (84%) of
dark yellow oil that was used directly since the primary amine is prone to oxidation. 1H NMR
(500 MHz, CDCl3) δ8.04 (d, J= 8.0 Hz, 1H, Ph-H), 7.85 (d, J= 8.0 Hz, 1H, Ph-H), 7.59-7.64 (m,
2H, Ph-H, Thy-H), 7.54-7.58 (m, 2H, Ph-H), 7.45-7.51 (m, 2H, Ph-H), 7.34-7.39 (m, 2H, Ph-H,
Thy-H), 6.65-6.69 (m, 2H, Ph-H), 3.80 (s, 2H, NH2), 1.83-2.00 (m, 4H, CH2), 0.99-1.28 (m,
28H, CH2), 0.83 (t, J= 7.0 Hz, 6H, CH3), 0.62-0.73 (m, 4H, CH2). 13C NMR (125 MHz, CDCl3)
δ 161.4, 153.8, 153.1, 150.7, 149.6, 146.4, 142.4, 135.0, 134.6, 131.6, 130.5, 129.5, 126.4, 125.1,
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124.7, 123.0, 122.8, 121.4, 120.8, 120.1, 118.8, 114.1, 109.7, 54.9, 40.6, 31.9, 30.1, 29.6, 29.5,
29.29, 29.28, 23.8, 22.7, 14.1.
Synthesis

of

7-(5-(benzothiazol-2-yl)thiophen-2-yl)-9,9-didecyl-N,N-diphenyl-9H-

fluoren-2-amine (I). 7-(5-(Benzothiazol-2-yl)thiophen-2-yl)-9,9-didecyl-9H-fluoren-2-amine 5

(130 mg, 0.19 mmol), iodobenzene (157 mg, 0.77 mmol), Cu-bronze (61 mg, 0.96 mmol), 18crown-6 (15 mg, 0.058 mmol), and K2CO3 (212 mg, 1.54 mmol) were combined with 1,2dichlorobenzene (3 mL). The mixture was heated to 180 C for 48 h. The crude product was
passed through a silica plug with CH2Cl2. The solvent was removed under reduced pressure and
the crude was purified by column chromatography on silica gel using as a solvent a mixture of
hexanes:EtOAc (9:1) to yield 150 mg (94%) of yellow solid (m.p. 107.5-109.5 C). 1H NMR
(500 MHz, CDCl3) δ 8.04 (d, J= 8.0 Hz, 1H, Ph-H), 7.84 (d, J= 8.0 Hz, 1H, Ph-H), 7.58-7.65
(m, 4H, Ph-H, Thy-H), 7.56 (d, J= 8.0 Hz, 1H, Ph-H), 7.45-7.50 (m, 1H, Ph-H), 7.33-7.39 (m,
2H, Ph-H, Thy-H), 7.22-7.30 (m, 5H, Ph-H), 7.11-7.16 (m, 5H, Ph-H), 7.00-7.05 (m, 2H, Ph-H),
1.82-1.95 (m, 4H, CH2), 1.01-1.23 (m, 28H, CH2), 0.85 (t, J= 7.0 Hz, 6H, CH3), 0.66-0.75 (m,
4H, CH2). 13C NMR (125 MHz, CDCl3) δ 161.3, 153.8, 152.5, 151.6, 149.2, 147.9, 147.5, 141.6,
135.4, 134.6, 131.4, 129.6, 129.5, 129.24, 129.16, 125.2, 125.0, 124.0, 123.9, 123.4, 123.3,
122.8, 122.6, 121.5, 121.4, 120.1, 105.0, 55.2, 40.2, 31.9, 30.0, 29.6, 29.6, 29.3, 23.9, 22.7, 14.1.
Anal. Calcd for C56H64N2S2: C, 81.11; H, 7.78; N, 3.38. Found: C, 80.81; H, 7.74; N, 3.30.
Synthesis

of

2,2'-(5,5'-(9,9-didecyl-9H-fluorene-2,7-diyl)bis(thiophene-5,2-

diyl))dibenzothiazole (II). 2-(5-(Tributylstannyl)thiophen-2-yl)benzothiazole 2 (460 mg, 0.90

mmol), 2,7-dibromo-9,9-didecyl-9H-fluorene 6 (250 mg, 0.41 mmol), and Pd(PPh3)2Cl2 (7.2
mg, 0.01mmol) were dissolved in toluene. The mixture was heated under reflux for 24 h. The
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solvent was removed under reduced pressure and the crude was purified by column
chromatography using a mixture of hexanes:EtOAc (9.9:0.1) to yield 126 mg (35%) of yellow oil
that solidified upon standing (m.p. 125.2-126.5 C). 1H NMR (500 MHz, CDCl3) δ 8.05 (d, J=
7.76 Hz, 2H, Ph-H), 7.87 (d, J= 7.82 Hz, 2H, Ph-H), 7.74 (d, J= 7.63 Hz, 2H, Ph-H), 7.68-7.71
(m, 2H, Ph-H), 7.64-7.67 (m, 4H, Ph-H, Thy-H), 7.47-7.52 (m, 2H, Ph-H), 7.43 (d, J= 4.10 Hz,
2H, Thy-H), 7.36-7.40 (m, 2H, Ph-H), 2.00-2.06 (m, 4H, CH2), 1.04-1.23 (m, 28H, CH2), 0.80 (t,
J= 7.04 Hz, 6H, CH3), 0.67-0.74 (m, 4H, CH2).

13

C NMR (125 MHz, CDCl3) δ 161.2, 153.7,

152.1, 148.8, 140.9, 135.8, 134.7, 132.6, 129.5, 126.5, 125.2, 125.0, 123.7, 122.9, 121.5, 120.5,
120.3, 55.4, 40.4, 31.9, 30.0, 29.6, 29.5, 29.3, 29.2, 23.8, 22.6, 14.1. HRMS (MALDI) m/z calcd
877.3712 [M+H]+, m/z found 877.3702 [M+H]+.
Synthesis of 4-(5-(benzothiazol-2-yl)thiophen-2-yl)-2-methylbut-3-yn-2-ol (7). 2-(5-

Bromothiophen-2-yl)benzothiazole 1 (200 mg, 0.67 mmol), 2-methyl-3-butyn-2-ol (170 mg, 2.02
mmol), Pd(PPh3)2Cl2 (19 mg, 0.027 mmol), and CuI (5 mg, 0.027 mmol) were dissolved in a 1:4
mixture of Et3N:toluene (5 mL). The mixture was heated under reflux for 12 h. After cooling to
room temperature, the mixture was filtered through a celite plug, and purified by column
chromatography using a mixture of hexanes:EtOAc (1:1) to yield 192 mg (96%) of pale yellow
solid (m.p. 163.9-164.6 C). 1H NMR (500 MHz, CDCl3) δ 8.02 (d, J= 8.04 Hz, 1H, Ph-H), 7.85
(d, J= 7.87 Hz, 1H, Ph-H), 7.50 (d, J= 3.95 Hz, 1H, Thy-H), 7.46-7.49 (m, 1H, Ph-H), 7.35-7.40
(m, 1H, Ph-H), 7.18 (d, J= 3.95 Hz, 1H, Thy-H), 2.11 (s, 1H, -OH), 1.64 (s, 6H, CH3). 13C NMR
(125 MHz, CDCl3) δ 160.4, 153.6, 137.9, 134.7, 132.9, 128.3, 126.4, 125.4, 123.1, 121.5, 121.4,
100.2, 75.2, 65.8, 31.3. Anal. Calcd for C16H13NOS2: C, 64.18; H, 4.38; N, 4.68. Found: C,
64.10; H, 4.33; N, 4.64.
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Synthesis of 2-(5-ethynylthiophen-2-yl)benzothiazole (8). 4-(5-(Benzothiazol-2-

yl)thiophen-2-yl)-2-methylbut-3-yn-2-ol 7 (300 mg, 1.0 mmol) and KOH (300 mg, 5.3 mmol)
were heated under reflux in toluene for 1 h. The mixture was filtered, then purified by column
chromatography eluting with hexanes to yield 180 mg (75%) of a white solid (m.p. 117.3-118.3
C). 1H NMR (500 MHz, CDCl3) δ 8.03 (d, J= 8.21Hz, 1H, Ph-H), 7.86 (d, J= 8.21Hz, 1H, PhH), 7.51 (d, J= 3.94 Hz, 1H, Thy-H), 7.47-7.50 (m, 1H, Ph-H), 7.37-7.42 (m, 1H, Ph-H), 7.28 (d,
J= 3.94 Hz, 1H, Thy-H), 3.50 (s, 1H, C≡C-H).

13

C NMR (125 MHz, CDCl3) δ 60.2, 153.6,

138.5, 134.8, 133.9, 133.7, 127.8, 126.5, 125.4, 123.2, 121.6, 84.0, 76.5. Anal. Calcd for
C13H7NS2: C, 64.70; H, 2.92; N, 5.80. Found: C, 64.64; H, 2.91; N, 5.75.
Synthesis

of

2-(5-((9,9-didecyl-7-nitro-9H-fluoren-2-yl)ethynyl)thiophen-2-

yl)benzothiazole (9). 2-(5-Ethynylthiophen-2-yl)benzothiazole 8 (180 mg, 0.75 mmol), 9,9-

didecyl-2-iodo-7-nitro-9H-fluorene 3 (460 mg, 0.75 mmol), Pd(PPh3)2Cl2 (20 mg, 0.03 mmol),
and CuI (5.6 mg, 0.03 mmol),were dissolved in a 1:4 mixture of Et3N:toluene (5 mL). The
mixture was heated under reflux for 12 h. After cooling to room temperature, the mixture was
filtered through a celite plug and purified by column chromatography eluting with a mixture of
hexanes:EtOAc (9:1), and then recrystallized from hexane to yield 300 mg (55%) of yellow solid
(m.p. 142.3-143.6 C). 1H NMR (500 MHz, CDCl3) δ 8.28 (dd, J= 8.40 Hz, J= 2.18 Hz, 1H, PhH), 8.21 (d, J= 2.05 Hz, 1H, Ph-H), 8.05 (d, J= 7.74 Hz, 1H, Ph-H), 7.88 (d, J= 7.74 Hz, 1H,
Ph-H), 7.77-7.82 (m, 2H, Ph-H), 7.55-7.61 (m, 3H, Ph-H, Thy-H), 7.48-7.52 (m, 1H, Ph-H),
7.39-7.42 (m, 1H, Ph-H), 7.33 (d, J= 4.08 Hz, 1H, Thy-H), 2.01-2.08 (m, 4H, CH2), 0.99-1.29
(m, 28H, CH2), 0.84 (t, J= 6.93 Hz, 6H, CH3), 0.50-0.64 (m, 4H, CH2).

13

C NMR (125 MHz,

CDCl3) δ 60.3, 153.7, 152.5, 152.3, 147.4, 146.6, 139.3, 138.4, 134.8, 132.8, 131.2, 128.5,
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128.3, 126.7, 126.2, 126.0, 123.2, 123.1, 121.6, 121.5, 120.2, 118.3, 105.0, 96.3, 83.8, 55.9, 40.0,
31.9, 29.9, 29.51, 29.48, 29.2, 23.8, 22.6, 14.14, 14.06. Anal. Calcd for C46H54N2O2S2: C, 75.57;
H, 7.45; N, 3.83. Found: C, 75.69; H, 7.47; N, 3.85.
Synthesis of 7-((5-(benzothiazol-2-yl)thiophen-2-yl)ethynyl)-9,9-didecyl-9H-fluoren2-amine (10). 2-(5-((9,9-Didecyl-7-nitro-9H-fluoren-2-yl)ethynyl)thiophen-2-yl)benzothiazole 9

(180 mg, 0.24 mmol) and 10% Pd/C (18 mg) were dissolved in a 1:1 mixture of THF:EtOH (4
mL). NH2NH2.2H2O (146 mg, 2.8 mmol) was added to the mixture dropwise at room
temperature, followed by heating to 110 C for 48 h. The mixture was filtered though a silica
plug with CH2Cl2, and, after removing the solvent under reduced pressure, the material was
purified by column chromatography using a mixture of hexanes:EtOAc (9:1) as eluent to yield
150 mg (87%) of dark yellow oil that was used immediately due to the oxidative lability of the
primary amine. 1H NMR (500 MHz, CDCl3) δ 8.03 (d, J= 7.45 Hz, 1H, Ph-H), 7.86 (d, J= 7.67
Hz, 1H, Ph-H), 7.56 (d, J= 3.99 Hz, 1H, Thy-H), 7.52 (d, J= 7.75 Hz, 1H, Ph-H), 7.46-7.50 (m,
3H, Ph-H), 7.43-7.44 (m, 1H, Ph-H), 7.36-7.40 (m, 1H, Ph-H), 7.27 (d, J= 3.99 Hz, 1H, Thy-H),
6.65-6.68 (m, 2H, Ph-H), 3.83 (s, 2H, NH2), 1.84-1.97 (m, 4H, CH2), 1.03-1.27 (m, 28H, CH2),
0.85 (t, J= 7.16 Hz, 6H, CH3), 0.56-0.68 (m, 4H, CH2). 13C NMR (125 MHz, CDCl3) δ 161.0,
160.6, 153.8, 153.1, 150.2, 149.9, 146.6, 146.0, 144.4, 142.7, 141.6, 136.1, 134.6, 133.7, 132.7,
132.2, 131.5, 128.4, 122.9, 121.6, 118.5, 114.0, 109.8, 97.7, 81.9, 54.9, 40.5, 31.9, 30.2, 29.7,
29.6, 29.4, 29.3, 23.9, 22.7, 14.2.
Synthesis

of

7-((5-(benzothiazol-2-yl)thiophen-2-yl)ethynyl)-9,9-didecyl-N,N-

diphenyl-9H-fluoren-2-amine

(III).

7-((5-(Benzothiazol-2-yl)thiophen-2-yl)ethynyl)-9,9-

didecyl-9H-fluoren-2-amine 10, (0.135 mg, 0.19 mmol), iodobenzene (157 mg, 0.77 mmol), Cu-
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bronze (61 mg, 0.96 mmol), 18-crown-6 (15 mg, 0.058 mmol), and K2CO3 (212 mg, 1.54 mmol)
were combined with, 1,2-dichlorobenzene (3 mL). The mixture was heated at 180 C for 48 h.
The crude product was passed through a silica plug with CH2Cl2. The solvent was removed
under reduced pressure, and the crude product was purified by column chromatography on silica
gel using a mixture of hexanes:EtOAc (9.5:0.5) as eluent to yield 81 mg (50%) of yellow viscous
oil. 1H NMR (500 MHz, CDCl3) δ 8.04 (d, J= 8.11 Hz, 1H, Ph-H), 7.85 (d, J= 8.11 Hz, 1H, PhH), 7.59 (d, J= 7.90 Hz, 1H, Ph-H), 7.56 (d, , J= 3.72 Hz, 1H, Thy-H), 7.45-7.52 (m, 4H, Ph-H),
7.35-7.39 (m, 1H, Ph-H), 7.24-7.30 (m, 5H, Ph-H), 7.10-7.15 (m, 5H, Phe-H), 7.00-7.05 (m, 3H,
Phe-H), 1.80-1.92 (m, 4H, CH2), 1.03-1.28 (m, 28H, CH2), 0.85 (t, J= 7.14 Hz, 6H, CH3), 0.620.69 (m, 4H, CH2).

13

C NMR (125 MHz, CDCl3) δ 160.5, 153.7, 152.6, 150.8, 147.8, 147.8,

141.9, 137.7, 135.2, 134.7, 132.4, 130.8, 129.2, 128.4, 127.4, 126.6, 125.7, 125.4, 124.0, 123.3,
123.01 122.7, 121.5, 120.9, 119.6, 119.1, 118.9, 97.4, 82.2, 55.2, 40.2, 31.9, 30.0, 29.6, 29.6,
29.4, 29.3, 23.9, 22.7, 14.1. Anal. Calcd for C58H64N2S2: C, 81.64; H, 7.56; N, 3.28. Found: C,
81.63; H, 7.62; N, 3.05.
Synthesis of 4,4'-(9,9-didecyl-9H-fluorene-2,7-diyl)bis(2-methylbut-3-yn-2-ol) (11).

2,7-Dibromo-9,9-didecyl-9H-fluorene 6 (1.0 g, 1.65 mmol), 2-methyl-3-butyn-2-ol (0.83 g, 9.92
mmol), Pd(PPh3)2Cl2 (95 mg, 0.135 mmol), and CuI (25 mg, 0.13 mmol) were dissolved in a 1:4
mixture of Et3N:toluene (15 mL). The mixture was heated under reflux for 12 h. After it was
cooled down, the mixture was filtered through a celite plug and purified by column
chromatography using hexanes as a eluent, followed by a mixture of hexanes:EtOAc (10:1) to
yield 0.64 g (63%) of white solid (m.p. 89.0-89.9 C). 1H NMR (500 MHz, CDCl3) δ 7.58-7.61
(m, 2H, Ph-H), 7.35-7.41 (m, 4H, Ph-H), 2.05 (s, 2H, -OH), 1.89-1.96 (m, 4H, CH2), 1.63-1.68
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(s, 12H, CH3), 0.98-1.27 (m, 28H, CH2), 0.85 (t, J= 6.49 Hz, 6H, CH3), 0.50-0.58 (m, 4H, CH2).
13

C NMR (125 MHz, CDCl3) δ 150.9, 140.6, 130.7, 126.0, 121.4, 119.8, 93.9, 83.0, 65.7, 55.2,

40.4, 31.9, 31.6, 30.0, 29.6, 29.5, 29.3, 29.2, 23.7, 22.6, 14.1. Anal. Calcd for C43H62O2: C,
84.53; H, 10.23. Found: C, 84.46; H, 10.25.
Synthesis

of

9,9-didecyl-2,7-diethynyl-9H-fluorene

(12).

4,4'-(9,9-Didecyl-9H-

fluorene-2,7-diyl)bis(2-methylbut-3-yn-2-ol) 11 (450 mg, 0.736 mmol) and KOH (206 mg, 3.68
mmol) were heated under reflux in toluene for 2 h. The mixture was filtered, then purified by
column chromatography using hexanes to yield 350 mg (97%) of light yellow oil. 1H NMR (500
MHz, CDCl3) δ 7.63 (dd, J= 7.73 Hz, J= 0.65 Hz, 2H, Ph-H), 7.48 (dd, J= 7.73 Hz, J= 1.42 Hz,
2H, Ph-H), 7.45-7.46 (m, 2H, Ph-H), 3.15 (s, 2H, C≡C-H), 1.90-1.96 (m, 4H, CH2), 0.99-1.25
(m, 28H, CH2), 0.85 (t, J= 7.0 Hz, 6H, CH3), 0.52-0.58 (m, 4H, CH2).

13

C NMR (125 MHz,

CDCl3) δ 151.0, 141.0, 131.2, 126.5, 120.8, 119.95, 84.5, 77.3, 55.2, 40.2, 31.9, 29.9, 29.5, 29.5,
29.2, 23.7, 22.7, 14.1. Anal. Calcd for C37H50: C, 89.81; H, 10.19. Found: C, 89.79; H, 10.24.
Synthesis

of

2,2'-(5,5'-(9,9-didecyl-9H-fluorene-2,7-diyl)bis(ethyne-2,1-

diyl)bis(thiophene-5,2-diyl))dibenzothiazole (IV). 9,9-Didecyl-2,7-diethynyl-9H-fluorene 12

(300 mg, 0.61 mmol), 2-(5-bromothiophen-2-yl)benzothiazole 1 (377 mg, 1.27 mmol),
Pd(PPh3)2Cl2 (34 mg, 0.05 mmol), and CuI (10 mg, 0.05 mmol) were dissolved in a 1:4 mixture
of Et3N:toluene (5 mL). The mixture was heated under reflux for 12 h. After it was cooled
down, the mixture was filtered through a celite plug, and purified by column chromatography
using a mixture of hexanes:EtOAc (10:1) as eluent to yield 310 mg (55%) of yellow solid (m.p.
74.0-75.5 C). 1H NMR (500 MHz, CDCl3) δ 8.04 (dd, J= 8.09 Hz, J= 0.54 Hz, 2H, Ph-H), 7.87
(dd, J= 8.04 Hz, J= 0.53 Hz, 2H, Ph-H), 7.70 (d, J= 7.83 Hz, 2H, Ph-H), 7.57 (d, J= 3.89 Hz,
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2H, Thy-H), 7.54-7.56 (m, 2H, Ph-H), 7.52-7.53 (m, 2H, Ph-H), 7.48-7.51 (m, 2H, Ph-H), 7.377.41 (m, 2H, Ph-H), 7.31 (d, J= 3.89 Hz, 2H, Thy-H), 1.97-2.04 (m, 4H, CH2), 1.04-1.23 (m,
28H, CH2), 0.84 (t, J= 6.96 Hz, 6H, CH3), 0.58-0.65 (m, 4H, CH2). 13C NMR (125 MHz, CDCl3)
δ 160.5, 153.7, 151.3, 141.1, 138.0, 134.7, 132.6, 130.8, 128.4, 127.1, 126.6, 125.9, 125.5, 123.1,
121.5, 121.3, 120.2, 97.0, 82.9, 55.4, 40.3, 31.9, 30.0, 29.6, 29.5, 29.3, 29.3, 23.8, 22.7, 14.1.
Anal. Calcd for C59H60N2S4: C, 76.58; H, 6.54; N, 3.03. Found: C, 76.79; H, 6.75; N, 2.79.
1.4.3 Measurements
Absorption spectra were recorded with an UV–visible spectrophotometer. Steady-state
fluorescence spectra were measured with a spectrofluorimeter in the photon counting regime of
the PMT using an L-format configuration. The fluorescence spectra were corrected for the
spectral dependence of the PMT. All measurements were performed in hexane at room
temperature in 1 cm quartz cuvettes, with dye concentrations on the order of 10-6 M.
Fluorescence quantum yields were determined relative to 9, 10-diphenylanthracene in
cyclohexane as a standard.[29]
Two-photon absorption (2PA) cross sections of the final compounds were determined by
the two-photon induced fluorescence method.[30] In this method, the sample is excited
simultaneously by two photons of low energy, resulting in fluorescence emission. The number
of photons emitted can be measured by a PMT, and the latter related to the numeric value of the
2PA cross section relative to a reference.
The 2PA cross section measurements were performed with a tunable 10 W pumped
Ti:sapphire femtosecond laser system (220 fs pulse width, 76 MHz repetition rate) as the
excitation source and a spectrofluorimeter with PMT detectors (Figure 1-7).
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The linear polarization and the power of the laser light were adjusted by the optical
attenuator (OA), which consists of two Glan-Thompsom polarizers and a half-waveplate. The
laser beam was divided with a beam splitter (BS) from where the transmitted beam was
expanded with a bean expander (BE) and passed through the sample (S) after being focused with
an objective lens (10X). The reflected beam was sent to the power meter (PM) to monitor the
variation of the incident power on the sample (S). The two-photon emission (2PE) light was
focused by the lens (L) and the upconverted fluorescence was collected by the PMT of the
spectrofluorimeter used for fluorescence quantum yield methods at a direction perpendicular to
the pump beam. During these measurements this PMT was set to analog mode. A computer was
used to record and process all the experimental data. The numerical estimation of the 2PA cross
section  was performed by comparison with a known reference by using equation (i):

  R

2

 I  C R n 2 QR PR
 I R  C nR 2 Q P 2

(i)

where the subscript R refers to the reference, <I > is the integrated intensity from two-photon
excitation, C is the concentration, n is the refractive index, Q is the quantum yield and P is the
incident power on the sample.
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OA: optical attenuator
BS: beam splitter
PM: power meter
BE: beam expander
10X: 10X objective lens

Figure 1-7 Experimental setup used to measure the 2PA cross sections of the dyes.

1.4.4 Cell culture and incubation
COS-7 and HCT 116 cell were cultured in DMEM, supplemented with 10% FBS, and 1%
penicillin, and 1% streptomycin at 37 °C, under 5% CO2 environment. N° 1 round 12 mm
coverslips were treated with poly-D-lysine to improve cell adhesion, and washed (3x) with PBS
buffer solution. The treated cover slips were placed in 24-well plates, seeded with 80,000
cells/well, and incubated at the same conditions as indicated above until 75-85% confluency was
reached on the coverslips. From a 4.10 x 10-4 M stock solution of dye I a series of 0.1, 1, 10, 20,
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and 50 µM solutions in DMSO were prepared with all solutions also containing 75 nM of
Lysotracker Red. These solutions were used to incubate the cells for 10 min to 3h. The dye
solutions were extracted and the coverslipped cells were washed abundantly with PBS (4x).
1.4.5 Cell fixing and mounting
Cells were fixed with 3.7% solution of paraformaldehyde in pH=7.4 PBS buffer for 10
min. The fixing agent was extracted and washed (2x) with PBS. To reduce autofluorescence, a
fresh solution of NaBH4 (1 mg/mL) in pH=8 PBS buffer was used to treat the fixed cells (2x).
The coverslipped cells were then washed with buffer PBS (2x) and mounted on microscope
slides using an antifade mounting media.
1.4.6 Confocal one-photon fluorescence imaging
One-photon (conventional) fluorescence microscopy images were recorded on an
inverted confocal microscope equipped with a EM-CCD digital camera. One-photon confocal
fluorescence images of the fixed cells were taken using a custom made filter cube (Ex:377/50;
DM: 409; Em:525/40) and a Texas Red filter cube (Ex:562/40; DM: 593; Em:624/40) for probe I
and Lysotracker Red, respectively.
1.4.7 Two-photon upconverted fluorescence imaging
Two-photon fluorescence microscopy (2PFM) imaging was performed on a modified
laser scanning confocal microscopy system equipped with a broadband, tunable Ti:sapphire laser
(220 fs pulse width, 76 MHz repetition rate), pumped by a 10 W frequency doubled Nd:YAG
laser. The Ti:sapphire laser, tuned 700 nm and modelocked, was used as the two-photon
excitation source.

Two-photon induced fluorescence was collected by a 60x microscope

objective (UPLANSAPO 60x, N.A.=1.35). A high transmittance (>95%) short-pass filter (cutoff
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685 nm) was placed in front of the PMT detector within the scanhead in order to filter off
background radiation from the laser source (700 nm).
1.5 Conclusions

Efficient synthetic routes were developed to prepare four new fluorescent compounds
containing functionalities such as thiophene and alkynyl moieties on a fluorene core, affording
systematic variation of molecular symmetry and extent of conjugation.

Comprehensive

characterization of the new compounds revealed excellent linear and nonlinear photophysical
properties, such as high fluorescent quantum yields (0.86-0.98) and high two-photon absorptivity
(220-1060 GM). Incorporation of thiophene and alkynyl moieties resulted in an increase in the
2PA cross section values. Probe I proved to have low cytotoxocity when incubated with COS-7
and HCT 116 cells, exhibiting endosomal selectivity, as evidenced by one-photon fluorescence
imaging and colocalization studies. The advantageous properties of probe I facilitated 2PFM
endosomal imaging, with the 2PFM images providing much better resolution, allowing the
visualization of individual endosomes. Due to their linear and nonlinear photophysical
properties, these new fluorenyl derivatives should find use in a number of emerging photonics
applications such as targeted two-photon fluorescence imaging and two-photon based optical
data storage.
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CHAPTER 2. TWO-PHOTON LYSOSOMAL BIOIMAGING WITH
MICELLE-ENCAPSULATED 2PA FLUORESCENT DYE
Carolina D. Andrade, Ciceron O. Yanez, Maher A. Qaddoura, Xuhua Wang, Curtesa L.
Arnett, Sabrina A. Coombs, Jin Yu, Rania Bassiouni, Mykhailo V. Bondar and Kevin D.
Belfield. Journal of Fluorescence. Accepted on November 2010.
2.1 Abstract

We report two-photon fluorescence microscopy (2PFM) imaging and in vitro cell viability of
a new, efficient, lysosome-selective system based on a two-photon absorbing (2PA) fluorescent
probe (IV) encapsulated in micelles formed with Pluronic® F-127. Preparation of probe IV was
accomplished via microwave-assisted synthesis, resulting in improved yields and reduced reaction
times. Photophysical characterization revealed notable 2PA efficiency of this probe.
Keywords: Fluorescent dyes, pluronics, multiphoton absorption, bioimaging,

fluorescence

microscopy, lysosomes.
2.2 Introduction

The advantages that 2PA materials offer over their one-photon absorbing counterparts
relies on the very nature of the nonlinear absorption process, where two photons are absorbed
simultaneously, offering increased 3D resolution as a result of a significantly confined excitation
volume.[31] This inherent advantage has increased the interest of the scientific community in
multiphoton imaging over the last decades, which has spawned the development of novel
multiphoton absorbing materials and their applications. The variety of applications of these
materials is witnessed in a number of fields, including microscopy,[1, 8] lasing,[15] and optical
data storage.[4, 32, 33] In the field of bioimaging, there has been increased attention in labeling
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different cell components or certain cells within a specific type of tissue by direct and indirect
immunostaining with efficient 2PA fluorescent dyes.[34, 35]
The lysosomes and their enzymes are the centerpiece of the digestive cycle of the cell
and, as such, are key in many cellular processes such as apoptosis and phagocytosis.
Lysosomal activity has been associated with an array of conditions including cancer,[36]
aging,[37] autophagy,[36, 38] and apoptotic and necrotic cell deaths,[36, 39] but the specific
role of the lysosomes in such processes remains a matter of some speculation. Furthermore,
the less common yet still severe conditions classified as Lysosomal Storage Disorders have
very serious clinical manifestations, such as mental retardation, progressive cognitive
decline, and behavioral inappropriateness.[40] Thus, methods and materials to that can
specifically probe lysosomes are of considerable interest.
The advent of fluorescence microscopy techniques that surpass the diffraction limit,
including 2PFM,[1] stimulated emission depletion (STED) microscopy,[41, 42] photoactivated localization microscopy (PALM),[43] and interferometric photo-activated
localization microscopy (iPALM),[44] have set the foundations for unforeseen resolution,
and will undoubtedly lead to more exciting discoveries, especially when these techniques are
combined to exploit superresolution to its very limit.[30] Even though there are
commercially available alternatives for imaging the lysosomes by fluorescence, very few of
the dyes or proteins employed possess the photostability and high two-photon absorption
cross sections to be efficient 2PA probes, particularly for prolonged imaging.
Pluronic® F-127 has been used in drug delivery applications to enhance the solubility
of hydrophobic substances such as anticancer drugs.[45, 46] Pluronic® micelles are known
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to be uptaken by MDCK cells by means of clathrin-mediated endocytosis when present
above the critical micelle concentration (CMC).[47-49] Probe IV was encapsulated in
Pluronic® F-127, with the purpose of it being endocytosed, and subsequently tracked
through the vesicle maturation process (Figure 2-1). After the micelles are endocytosed they
can either reach full endosomal maturation, reaching the lysosomes, or follow exocytosis
before attaining the endolysosomal stage.

Figure 2-1 Depiction of Pluronic® F-127-encapsulated 2PA probe IV being uptaken into an HCT 116
cell by means of clatherin-mediated endocytosis. After 3 h of incubation, IV can be found in lysosomes.

2.3 Results and Discussion

2.3.1 Synthesis of new fluorescent probes
The strategy for the synthesis of probe IV is outlined in Scheme 2-1. Thiophene 1
underwent Sonogashira coupling with a protected terminal alkyne to yield intermediate 7 (12
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h).

The microwave-assisted equivalent of this reaction reached completion 360 times

faster.[14] Deprotection of the triple bond in intermediate 7 was also performed under
microwave irradiation, generating 8 in higher yield and shorter reaction time when compared
to conventional thermal deprotection. A second Sonogashira coupling, between 8 and 6, was
required to generate probe IV; this microwave-assisted reaction afforded the product in
slightly higher yield and shorter time (20 times faster) than conventional heating.
Scheme 2-1
2-methyl-3-butyn-2-ol, Pd(PPh3 )2 Cl 2
CuI, Et3 N, toluene
Br thermal: ref lux, 12 h (96%)
microwave: 130 o C, 2 min (96% )

N
S
S

N

N

Pd(PPh3)2 Cl2, CuI, Et3 N, toluene
thermal: reflux, 20 h (55%)
microwave: 130 o C, 1h (65%)

N
S

C10H2 1 C10H2 1

KOH, toluene
thermal: reflux 2 h (75%)
microwave: 130 oC, 8 min (98%)

(7)

(1)

S

OH
S

S

S

S
Br

C10H21 C10H21

N

S

S
(8)

Br
(6)
(IV)

2.3.2 Linear photophysical properties
The hydrophobic character of probe IV made it an ideal candidate for encapsulation
in Pluronic® F-127. Steady state, linear absorption, and fluorescence properties of solutions
of IV in hexane and with the Pluronic® surfactant in PBS buffer were measured (Figure 2-2).
Absorption maxima at around 400 nm were observed for IV in both solvent systems. The
emission maximum shifted towards longer wavelengths when IV was prepared in Pluronic®
solution as a consequence of the increase in polarity of the media. In hexane, the
fluorescence quantum yield of IV was 0.95, while nonradiative decay led to a reduction to
one third of this value when the dye was dissolved in the aqueous Pluronic® solution (see
Table 2-1).
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Figure 2-2 Absorption (solid) and emission (broken) spectra of 2PA probe IV in hexane (red) and
encapsulated in Pluronic® F-127 (PBS solution, green).

Table 2-1 Linear optical properties of probe IV.

1

Compound

λabsmax (nm)

λemmax (nm)

Φ1

IV in hexane

397±1

433±1

0.95±0.05

IV in Pluronic®F-127
/PBS

403±1

485±1

0.35±0.05

Fluorescence quantum yield, Φ, measured relative to 9,10-diphenylanthracene in cyclohexane.
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2.3.3 Nonlinear photophysical properties
Two-photon absorption cross section values of solutions of IV in cyclohexane,
DMSO, and 5 wt% aqueous DMSO were determined using the two-photon fluorescence
method from 640 to 920 nm, a convenient wavelength range for 2PFM imaging (Figure 2-3).
2PA at these wavelengths was consistent for symmetrical 2PA dyes. Since adherence to the
selection rules are typically more stringent for symmetrical dyes, high cross 2PA sections at
twice the linear max are seldom observed for this type of compound (Figure 2-2).[29, 50]
The highest 2PA cross section values were observed at 680 nm for all solvents used, which is
likely the maximum of the lower energy two-photon allowed transition. Even though the
lowest 2PA cross sections were observed in the aqueous mixture, a value of 250 GM at ca.
700 nm is quite good. This and the fluorescence quantum yield of IV proved favorable for
2PFM imaging.

Figure 2-3 2PA spectra of 2PA probe IV in cyclohexane (1), DMSO (2) and 5 wt% aqueous DMSO (3).
Normalized one-photon absorption spectrum of IV in cyclohexane (4).
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2.3.4 Fluorescence imaging
HCT 116 cells were incubated in Pluronic® F-127 encapsulated 2PA probe IV. A
series of 0.1, 1, 10, 25, and 50 µM solutions of the micelle-encapsulated probe in culture
media was prepared. Another identical series, also containing 75 nM of Lysotracker Red
(Invitrogen), was prepared for colocalization studies to determine whether the micelleencapsulated probe reached the lysosomes. HCT 116 cells were incubated in these solutions
for 3 h.

After fixation, the one-photon fluorescence images exhibited good agreement

between the Lysotacker Red (Figure 2-4B) and the Pluronic® F-127-encapsulated 2PA probe
IV (Figure 2-4C), as shown by the overlay of micrographs of these two channels (Figure 2-

4D). The excellent colocalization agreement was further confirmed by the calculation of the
colocalization coefficient which was determined to be  0.91.[51]

Figure 2-4 Confocal fluorescence images of HCT 116 cells incubated with 2PA probe IV encapsulated
in Pluronic® F-127 (25 M, 3 h) and Lysotracker Red (100 nM, 3 h). DIC (A), one-photon fluorescence
image showing Lysotracker Red (B) and 2PA probe IV encapsulated in Pluronic® F-127 micelles (C).
(D) is colocalization (overlay of B and C). 10 m scale bar.
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Cell viability assays were conducted with CellTiter 96 AQ (Promega).

In this

assay, the ability of the cell to metabolize MTS to formazan was evaluated. Formazan has an
absorption (max 490 nm) that is significantly red-shifted with respect to MTS. Hence, by
interrogation at 490 nm, one can approximate the proportion of cells that are metabolically
active or viable. To evaluate the effect of the micelle-encapsulated probe IV, COS-7 and
HCT 116 cells were seeded (5 x 103 cells/well) in a 96 well plate and incubated for 24 h in
DMEM (Invitrogen). The cells were incubated with 60, 50, 25, 10, and 1 M solutions of
Pluronic F-127-encapsulated probe IV for 24 h.

The results indicated that these

concentrations did not significantly affect either cell line. Even at concentrations above those
used for imaging, the cell viability is practically 100% (see Figure 2-5), compelling data to
support the use of this probe for in vivo two-photon fluorescence imaging.

Figure 2-5 Cell viability assays of COS-7 and HCT 116 cells incubated with Pluronic® F-127encapsulated 2PA probe IV.
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Two-photon fluorescence microscopy (2PFM) images of fixed HCT 116 cells
incubated with probe IV encapsulated in Pluronic® F-127 (50 M, 3 h ) were collected on a
modified Olympus Fluoview FV300 microscope system coupled to a tunable Coherent Mira
900F Ti:sapphire, 76 MHz, modelocked, 200 fs laser tuned to 700 nm (Figure 2-6C).
Two-photon fluorescence imaging, Figure 2-6C, revealed remarkable contrast when
compared to one-photon (conventional) fluorescence imaging, Figure 2-6B, in which individual
lysosomes become evident. This demonstrates the potential that this probe-micelle formulation
has for following the endocytotic process by 2PFM. Furthermore, the versatility of this system
should allow one to encapsulate a wide variety of 2PA hydrophobic dyes, an aspect of further
investigation.

Figure 2-6 One-and two-photon fluorescence micrographs of HCT 116 cells incubated with probe IV
encapsulated in Pluronic® F-127 (50 M, 3 h). DIC (A), one-photon fluorescence (B), and 3D
reconstruction from overlaid 2PFM images (C), 76 MHz, 200 fs laser 700 nm, 60x objective (NA= 1.35,
Olympus). Scale: 10 μm grid.
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2.4 Experimental Section

2.4.1 Materials and methods
2-(5-Bromothiophen-2-yl)benzothiazole 1 and 2,7-dibromo-9,9-didecyl-9H-fluorene 6
were prepared as described previously.[27, 28] Synthesis of compounds 7 and 8 has been
achieved previously by conventional heating, and dye IV was prepared trough a different
methodology.[52] All microwave reactions were carried out under N2 in a CEM Discover unit
microwave in 10 mL closed vessels programmed at a maximum temperature of 130 oC,
maximum pressure of 100 psi and maximum power of 100 Watts. All other reagents and solvents
were used as received from commercial suppliers. 1H and

13

C NMR spectra were recorded in

CDCl3 on a Varian NMR spectrometer at 500 and 125 MHz, respectively. Elemental analyses
were performed by Atlantic Microlab, Inc.
2.4.2 Synthetic procedures and characterization
Synthesis of 4-(5-(benzothiazol-2-yl)thiophen-2-yl)-2-methylbut-3-yn-2-ol (7): 2-(5-

Bromothiophen-2-yl)benzothiazole 1 (200 mg, 0.67 mmol), 2-methyl-3-butyn-2-ol (170 mg, 2.02
mmol), Pd(PPh3)2Cl2 (19 mg, 0.027 mmol) and CuI (5 mg, 0.027 mmol) were dissolved in a 1:4
mixture of Et3N:toluene (5 mL). The mixture was either heated under reflux for 12 hours or
irradiated in the microwave for 2 minutes, when it was determined by TLC that the reaction was
completed. The mixture was filtered through a celite plug, and purified by column
chromatography using as a solvent a mixture of hexane:ethyl acetate (1:1) to yield 192 mg (96%)
of a pale yellow solid when the heating was achieved by either method. m.p. 163.9-164.6 oC. 1H
NMR (500 MHz, CDCl3) δ8.02 (d, J=8.04Hz, 1H, Ph-H), 7.85 (d, J=7.87Hz, 1H, Ph-H), 7.50 (d,
J=3.95 Hz, 1H, Thy-H), 7.47 (m, 1H, Ph-H), 7.38 (m, 1H, Ph-H), 7.18 (d, J=3.95 Hz, 1H, Thy-
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H), 2.11 (s, 1H, -OH), 1.64 (s, 6H, CH3).

13

C NMR (125 MHz, CDCl3) δ 160.4, 153.6, 137.8,

134.7, 132.9, 128.3, 126.4, 125.3, 123.1, 121.5, 121.4, 100.2, 75.2, 65.8, 31.3.Anal. Calcd for
C16H13NOS2: C, 64.18; H, 4.38; N, 4.68. Found: C, 64.10; H, 4.33; N, 4.64.
Synthesis of 2-(5-ethynylthiophen-2-yl)benzothiazole (8): 4-(5-(Benzothiazol-2-

yl)thiophen-2-yl)-2-methylbut-3-yn-2-ol 7 (300 mg, 1.0 mmol) and KOH (300 mg, 5.3 mmol)
were heated either under reflux for 1 hour or under microwave irradiation for 8 minutes. The
mixture was filtered, and then purified by column chromatography using as a solvent hexane to
yield 180 mg (75%) by the conventional heating method or 236 mg (98%) by the microwave
assisted method of a pale yellow solid. m.p. 117.3-118.3 oC. 1H NMR (500 MHz, CDCl3) δ 8.03
(d, J=8.21Hz, 1H, Ph-H), 7.86 (d, J=8.21Hz, 1H, Ph-H), 7.51 (d, J=3.94 Hz, 1H, Thy-H), 7.48
(m, 1H, Ph-H), 7.39 (m, 1H, Ph-H), 7.28 (d, J=3.94 Hz, 1H, Thy-H), 3.50 (s, 1H, C≡C-H). 13C
NMR (125 MHz, CDCl3) δ 60.2, 153.6, 138.5, 134.8, 133.9, 133.7, 127.8, 126.5, 125.4, 123.2,
121.6, 84.0, 76.5. Anal. Calcd for C13H7NS2: C, 64.70; H, 2.92; N, 5.80. Found: C, 64.64; H,
2.91; N, 5.75.
Synthesis

of

2,2'-(5,5'-(9,9-didecyl-9H-fluorene-2,7-diyl)bis(ethyne-2,1-

diyl)bis(thiophene-5,2-diyl))dibenzothiazole (IV): 2,7-dibromo-9,9-didecyl-9H-fluorene 6

(300 mg, 0.50 mmol), 2-(5-ethynylthiophen-2-yl)benzothiazole 8 (263 mg, 1.09 mmol),
Pd(PPh3)2Cl2 (30 mg, 0.04 mmol) and CuI (8 mg, 0.04 mmol), were dissolved in a 1:4 mixture of
Et3N:toluene (5 mL). The mixture was heated under reflux for 12 hour or in the microwave for
1h. The mixture was filtered through a celite plug, and purified by column chromatography using
as a solvent a mixture of hexane:ethyl acetate (10:1) to yield 252 mg (55%) of a yellow solid by
conventional heating and 298 mg (65%) when microwave irradiation was used. m.p. 74.0-75.5
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o

C. 1H NMR (500 MHz, CDCl3) δ 8.04 (dd, J=8.09 Hz, J=0.54 Hz, 2H, Ph-H), 7.87 (dd, J=8.04

Hz, J=0.53 Hz, 2H, Ph-H), 7.70 (d, J=7.83 Hz,2H, Ph-H), 7.57 (d, J=3.89 Hz, 1H, Thy-H), 7.55
(m, 2H, Ph-H), 7.53 (m, 2H, Ph-H), 7.49 (m, 2H, Ph-H), 7.39 (m, 2H, Ph-H), 7.31 (d, J=3.89
Hz, 1H, Thy-H), 2.00 (m, 4H, CH2), 1.15 (m, 28H, CH2), 0.84 (t, J=6.96 Hz, 6H, CH3), 0.61 (m,
4H, CH2). 13C NMR (125 MHz, CDCl3) δ 160.5, 153.7, 151.3, 141.1, 138.0, 134.7, 132.6, 130.8,
128.4, 127.1, 126.6, 125.9, 125.5, 123.1, 121.5, 121.3, 120.2, 97.0, 82.8, 55.4, 40.3, 31.9, 30.0,
29.6, 29.5, 29.3, 29.3, 23.8, 22.7, 14.1. Anal. Calcd for C59H60N2S4: C, 76.58; H, 6.54; N, 3.03.
Found: C, 76.79; H, 6.75; N, 2.79.
2.4.3 Measurements
Absorption spectra were recorded with an Agilent 8453 UV–visible spectrophotometer.
Steady-state fluorescence spectra were measured with a PTI Quantamaster spectrofluorimeter in
the photon counting regime of the PMT using an L-format configuration. The fluorescence
spectra were corrected for the spectral dependence of the PMT. All measurements were
performed in hexane at room temperature in 1 cm quartz cuvettes, with dye concentrations in the
order of 10-6 M. Fluorescence quantum yields were determined relative to 9, 10diphenylanthracene in cyclohexane as a standard.
Two-photon absorption spectra of IV were measured at 700, 750 and 800 nm in
spectroscopic grade nonpolar cyclohexane, polar DMSO and aqueous mixtures by a typical twophoton fluorescence 2PF method relative to Rhodamine B in methanol as a standard.[53] The
setup comprised a PTI QuantaMaster spectrofluorimeter coupled to a femtosecond Clark-MXR
CPA-2010 laser that pumped optical parametric generator/amplifiers (TOPAS) with tuning range
600-950 nm, pulse duration  140 fs (FWHM), 1 kHz repetition rate and pulse energies up to ~
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0.15 J. Two-photon fluorescence measurements were performed in 10 mm quartz cuvettes with
dye concentrations ~ 10-5 M. The values of 2PA cross section, 2PA, were determined by the
equation (ii):

 2SPA   2RPA 

 F (t ) S  C R   R   R   P(t ) 2R
 F (t ) R  C S   S   S   P(t ) 2S

(ii)

where <F(t)>, <P(t)>, C and , are the averaged fluorescence intensity, excitation power,
molecular concentration and geometric factor, respectively. Subscripts S and R refer to the
sample and reference compound. [54] The quadratic dependence of 2PF intensity on the
excitation power was checked for every excitation wavelength, ex, and special attention was
paid to verify the independence of the fluorescence quantum yield from ex.
2.4.4 Cell culture and incubation
HCT 116 cell were cultured in DMEM, supplemented with 10% FBS, and 1% penicillin,
1% streptomycin, at 37 °C, under 5% CO2 environment. N° 1 round 12mm coverslips were
treated with poly-D-lysine, to improve cell adhesion, and washed (3x) with PBS buffer solution.
The treated cover slips were placed in 24-well plates and 80,000 cells/well were seeded and
incubated at the same conditions as indicated above until 75%-85% confluency was reached on
the coverslips. From a 3.03 x 10-4 M stock solution of Pluronic® F-127 encapsulated dye IV a
series of 0.1, 1, 10, 25, and 50 µM solutions in culture media were made all of them also
containing 75 nM of Lysotracker Red (Invitrogen). These solutions were used to incubate the
cells for 3h.

The dye solutions were extracted and the coverslipped cells were washed

abundantly with PBS (4x).
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Cell fixing and mounting: Cells were fixed with 3.7% solution of paraformaldehyde in
pH=7.4 PBS buffer for 10 min. The fixing agent was extracted and washed (2x) with PBS. To
reduce autofluorescence, a fresh solution of NaBH4 (1 mg/mL) in pH=8 PBS buffer was used to
treat the fixed cells (2x). The coverslipped cells were then washed with buffer PBS (2x) and
mounted on microscope slides using Prolong Gold (Invitrogen) as a mounting media.
2.4.5 Cell viability
Cell viability was assessed with CellTiter 96 AQ (Promega). COS-7 and HCT 116
cells were seeded (5x103 cells/well) in a 96 well plate and incubated for 24 h in 90 L of DMEM
(Invitrogen) without phenol red, supplemented with 10% FBS (Atlanta Biologicals), and 1%
penicillin-streptomycin. The cell was incubated for an additional 24 h with 60, 50, 25, 10 and 1
M solutions of Pluronic F-127-encapsulated dye IV in FBS complemented (10%) culture
media.

Then 20 M of the CellTiter 96 AQ reagent was added into each well and

subsequently incubated for another 4 h, 37 C after which the respective absorbance values were
read on a SpectraMax M5 plate reader (Molecular Devices) at 490 nm to determine the relative
amount of formazan produced. Cell viability % was calculated by the following expression (iii):

Cell

viability(%) 

S
B
Abs490nm
 Abs490nm
x100%
B2
AbsC490nm  Abs490nm

(iii)

where AbsS490nm is the absorbance of the cells at the different concentrations of micelle
encapsulated dye IV, AbsB490nm is the absorbance of a cell-free well containing only
encapsulated dye IV in at the concentrations that were studied, AbsC490nm is the absorbance of
cells incubated in media without any other component, and AbsB2490nm is the absorbance of a
cell-free well.
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2.4.6 Confocal one-photon fluorescence imaging
One-photon fluorescence microscopy images were recorded on an Olympus IX81confocal microscope equipped with a Hamamatsu EM-CCD C9100 digital camera. Onephoton confocal fluorescence images of the fixed cells were taken using a custom made filter
cube (Ex:377/50; DM: 409; Em:525/40) and a Texas Red filter cube (Ex:562/40; DM: 593;
Em:624/40) for dye IV and Lysotracker Red, respectively.
2.4.7 Two-photon upconverted fluorescence imaging
Two-photon fluorescence imaging was performed on a modified Olympus Fluoview
FV300 laser scanning confocal microscopy system equipped with a broadband, tunable Coherent
Mira Ti:sapphire laser (115 fs pulse width, 76 MHz repetition rate), pumped by a 10 W Coherent
Verdi frequency doubled Nd:YAG laser. The laser was tuned and modelocked to 700 nm and
used as the two-photon excitation source. The two-photon induced fluorescence was collected
by a 60x microscope objective (UPLANSAPO 60x, N.A.=1.35 Olympus). A high transmittance
(>95%) short-pass filter (cutoff 685 nm, Semrock) was placed in front of the PMT detector
within the FV300 scanhead in order to filter off background radiation from the laser source (700
nm).
2.5 Conclusions

Encapsulation of hydrophobic 2PA probe IV in Pluronic® F-127 is a viable method
for delivering the fluorescent probes into the the lysosomes of HCT 116 cells.

After

photophysical characerization, the fluorene-based fluorescent probe IV proved to have high
2PA cross sections in polar solvents, and good fluorescence quantum yields. The yields and
reaction times of this probe were significantly improved by the use of microwave-assisted
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synthetic procedures. 2PFM imaging revealed remarkable contrast when compared to the
one-photon fluorescence, suggesting the potential that this probe-micelle formulation has in
bioimaging. Cell viability assays, carried out for HCT 116 and COS-7 cells, indicate that the
probe concentrations used for imaging purposes are virtually harmless to HCT 116 and COS7 cells.
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CHAPTER 3. NEW TWO-PHOTON ABSORBING PROBE WITH
EFFICIENT SUPERFLUORESCENT PROPERTIES
Reproduced with permission from: Kevin D. Belfield, Carolina D. Andrade, Ciceron O.
Yanez, Mykhailo V. Bondar, Florencio E. Hernandez, Olga V. Przhonska, Journal of Physical
Chemistry B, 2010, 114, 14087-14095. Copyright 2010 American Chemical Society.

3.1 Abstract

The synthesis, linear photophysical and photochemical parameters, two-photon
absorption (2PA), and superfluorescence properties of 2,2'-(5,5'-(9,9-didecyl-9H-fluorene-2,7diyl)bis(ethyne-2,1-diyl)bis(thiophene-5,2-diyl))dibenzo[d]thiazole

(IV)

were

investigated,

suggesting its potential as an efficient fluorescent probe for bioimaging applications. The steadystate absorption, fluorescence, and excitation anisotropy spectra of IV were measured in several
organic solvents and aqueous media. Probe IV exhibited high fluorescence quantum yield (~ 0.70.8) and photochemical stability (photobleaching quantum yield ~ (3 - 7)10-6). The 2PA spectra
were determined over a broad spectral range (640-920 nm) using a standard two-photon induced
fluorescence method under femtosecond excitation. A well-defined two-photon allowed
absorption band at 680-720 nm with corresponding 2PA cross sections 2PA  800-900 GM was
observed. The use of probe IV in bioimaging was shown via one- and two-photon fluorescence
imaging of HCT-116 cells. An amplification of the stimulated emission of IV was demonstrated
in organic solvents and thin polystyrene films, which potentially can be used for the development
of new fluorescent labels with increased spectral brightness.
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3.2 Introduction

The development of new highly fluorescent organic compounds with efficient twophoton absorption (2PA) properties is a subject of broad scientific and technological interest for
a number of multidisciplinary applications,[1, 33, 55-59] including 3D biological imaging by
two-photon fluorescence microscopy (2PFM) methods.[1, 58, 59] Directional synthesis of new
fluorescent labels and comprehensive investigations of their linear photophysical, nonlinearoptical and photochemical properties can appreciably extend the abilities of bioimaging
applications. High fluorescence quantum yield, , large values of 2PA cross sections, 2PA , as
well as their product,   2 PA  2actPA (so-called two-photon action cross section[60]), and
photochemical stability under high intensity laser irradiation are the primary properties required
for 2PFM-based applications of organic chromophores.[54, 61, 62] A number of potential
fluorescence labels with suitable 2PA properties have been synthesized for two-photon
bioimaging use (see, e.g., nonlinear optical properties of water soluble [2.2]paracyclophaneact
,[60] 2,6-bis(p-dialkylaminostyryl)anthracene
based fluorophores with high values of 2PA

derivatives,[63] and dipyrrylmetheneboron difluoride compounds[64]). Among these, high twophoton absorbing fluorene-based derivatives are promising fluorescent labels for 2PFM
bioimaging applications.[8, 34, 65] In addition to strong 2PA transitions, fluorene derivatives
exhibit efficient stimulated emission depletion[66] and lasing properties,[15] which can
dramatically improve the quality and scope of microscopic images and techniques.
In this paper, we report a new fluorene-based probe, 2,2'-(5,5'-(9,9-didecyl-9H-fluorene2,7-diyl)bis(ethyne-2,1-diyl)bis(thiophene-5,2-diyl))dibenzo[d]thiazole

(IV),

[52]

and

comprehensive characterization of its linear photophysical, 2PA, superfluorescence, and lasing
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properties in isotropic solutions. The rationale for the molecular design of this compound was
previously described. [52] Linear photophysical investigations include a detailed analysis of the
nature of absorption bands by excitation anisotropy, [67] along with fluorescence lifetime and
quantum yield measurements, in various organic solvents and aqueous media. 2PA spectra of
probe IV were obtained over a broad spectral range by a two-photon induced fluorescence (2PF)
method.[54] Probe IV was encapsulated in Pluronic F127 and used as a fluorescent probe to
image endosomes and lysosomes via one- and two-photon fluorescence microscopy in HCT-116
cells. The investigation of the broad range of excited state absorption (ESA) spectra,
superfluorescence, and lasing potential of IV is just the first step in the development of new
types of organic labels with high spectral brightness for fluorescence microscopy applications.
3.3 Results and Discussion

3.3.1 Linear photophysical properties
Probe IV was prepared in three steps as shown in Figure 3-1. Each of the three steps was
accomplished by either thermal or microwave-facilitated heating. In each case, the microwaveassisted reaction occurred at significantly shorter times. While the conventional (thermal) and
microwave-assisted reaction yields were the same for the first step, microwave-facilitated
reactions provided high yields of product for the latter two steps.
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Figure 3-1 Multistep synthesis of probe IV.

The main linear photophysical and photochemical parameters of new symmetrical
fluorene derivative IV with alkynyl triple bonds in the chromophore system, along with the
steady-state absorption and fluorescence spectra in various organic solvents are presented in
Table 3-1 and Figure 3-2, respectively. The shape of absorption spectra and maximum values of
extinction coefficients,  max , were independent of molecular concentration up to C  10-2 M,
which is indicative of negligible aggregation effects. As can be seen in Figure 3-2, linear onephoton absorption spectra of IV in all of the investigated solvents were nearly independent of
solvent polarity, f , and exhibited relatively high extinction coefficients  max ~ 105 M-1cm-1 in
the long wavelength absorption bands. In contrast, the steady-state fluorescence spectra of IV
(Figure 3-2, curves 1’-7’) exhibited noticeable solvatochromic behavior with relatively strong
vibronic structure, even in the polar solvent DMSO. Dramatic changes in the shape of the
fluorescence spectra of symmetrical fluorene derivatives with extended -conjugation are typical
for donor-acceptor fluorenes[66, 68] and can be explained by symmetry breaking effects
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occurring in the first excited state, S1, after electronic excitation.[69] All fluorescence spectra of
IV were independent of excitation wavelength, ex , and exhibited high fluorescence quantum

yield (  ~ 0.7 - 0.8) in all organic solvents. The fluorescence decay curves corresponded to a
single-exponential decay process with  ~ 0.7 - 0.8 ns (see Table 3-1), indicative of the
relatively fast spontaneous relaxation, with velocity 1/  n   /  ~ 109 s-1, where  n is the
natural lifetime. [67]
In aqueous solution probe IV exhibited nearly the same steady-state absorption spectrum
as in organic media, with an increased Stokes shift, substantial decrease in fluorescence quantum
yield, and bi-exponential fluorescence decay (see Table 3-1) with the primary short component 
0.46 ns (~ 95 % amplitude). It should be noted that in an aqueous medium, the shape of
fluorescence spectrum of IV and the value of its quantum yield,  , were also independent of

ex . The nature of this spectral behavior is not sufficiently clear and will be the subject of further
investigation.
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Table 3-1 Major linear photophysical parameters of IV in different solvents with corresponding polarity
max
f and viscosity  : absorption max
maxima, Stokes shifts, maximum
abs and fluorescence  fl
extinction coefficients  max , quantum yields  , fluorescence lifetimes  and photobleaching quantum
yields,  Ph , under one-photon excitation.

Cyclo-

Aqueous

Toluene

THF

DCM

DMSO

ACN

710-4

0.0135

0.209

0.217

0.263

0.305

0.321

0.313

0.97

0.59

0.48

0.4

2.0

0.34

0.6

max
abs , nm

397  1

399  1

402  1

401  1

403  1

404  1

398  1

406  1

max
fl , nm

433  1

436  1

441  1

441  1

445  1

451  1

441  1

488  1

Stokes
shift, nm

36  2

37  2

39  2

40  2

42  2

47  2

43  2

82  2

110  7

105  5

104  5

104  5

107  5

90  10

-

63  10

0.81

0.80

0.8

0.77

0.78

0.72

0.76

0.14

 0.05

 0.05

 0.05

 0.05

 0.07

 0.05

 0.05

 0.02

0.73

0.72

0.70

0.75

0.73

0.80

0.80

0.460.05

 0.04

 0.04

 0.04

 0.04

 0.05

 0.04

 0.04

1.7  0.3

35  6

5.7  0.9

-

45  10

N/N

Hexane

f

810-5

, cP

 max 10-3,
M-1cm-1


 , ns

hexane

 Ph 106 7.0  1.0 3.1  0.6 3.2  0.6 3.3  0.7
* Water (95 wt%) and DMSO (5 wt%).
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mixture*

Normalized Absorbance

1.0
0.8
0.6

1-Hexane
2-ACN
3-CyHex
4-THF
5-Toluene
6-DCM
7-DMSO

1-7 1'-7'

1'-Hexane
2'-CyHex
3'-Toluene
4'-THF
5'-ACN
6'-DCM
7'-DMSO

1.0
0.8
0.6

0.4

0.4

0.2

0.2

0.0

300

400

500

600

Normalized Fluorescence

1.2

1.2

0.0

Wavelength, nm

Figure 3-2 Normalized one-photon absorption (1-7) and fluorescence (1’-7’) spectra of IV in organic
max
solvents. Corresponding solvents are listed in the order of increasing wavelength max
abs and  fl .

The excitation anisotropy spectra of IV in organic solvents and in viscous polyTHF
(pTHF) are presented in Figure 3-3. In low viscosity solvents (hexane, toluene, ACN, etc.) the
anisotropy values, r , decreased due to rotational movement of the molecule in accordance with

r  r0 /(1   /  ) , where r0  (3 cos 2   1) / 5 is the fundamental anisotropy value (  is the angle
between absorption S0  S1 and emission S1  S0 transition dipole moments) and  is the
rotational correlation time.[67] In viscous pTHF at room temperature the fluorescence lifetime τ
<< θ ( θ = ηV / kT > 10 ns; V is the volume of the molecule, k and T are the Boltzmann constant
and absolute temperature, respectively). Therefore, in pTHF excitation anisotropy reached its
maximum value r  r0  0.38 (Figure 3-3a, curve 1), which is close to theoretical limit 0.4,
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reflecting a nearly parallel orientation of the absorption and emission transition dipoles. In this
case, it is possible to determine the mutual dipole orientation for the S0  S1 and higher excited
S0  Sn (n = 2, 3, …) electronic transitions.
Excitation anisotropy spectra provided information regarding the nature of the onephoton absorption bands. From Figure 3-3a, curve 1, the value of anisotropy was not sufficiently
constant in the main long wavelength absorption band (see, for comparison, anisotropy spectra of
typical fluorene derivatives[50, 68, 70]). This suggests that more than one electronic transition
with different dipole orientations corresponded to the main absorption band. Following extremes
or constant values in the anisotropy spectra in the short wavelength region, the spectral positions
of another S0  Sn absorption band was indicated. Normalization of excitation anisotropy
spectra in different organic solvents, r (ex ) , with respect to the excitation anisotropy spectrum in
hexane, rhex (ex ) , are presented Figure 3-3b and d. Nearly constant values of r / rhex in the
spectral range 280 nm  ex  450 nm (Figure 3-3b) reflect similar mutual orientations of the
corresponding electronic transitions S0  Sn (n = 1, 2, 3,…) of IV in hexane, cyclohexane, THF,
DCM, and ACN. In contrast, mutual orientation of the electronic transitions in toluene, DMSO,
and pTHF (see corresponding functions r / rhex  f (ex ) in Fig. 3-3d) exhibited different types of
solvent influence on the electronic structure of IV.
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Figure 3-3 (a) Excitation anisotropy spectra of IV in pTHF (1), DMSO (2), cyclohexane (3), toluene (4),
THF (5), DCM (6), hexane (7), and ACN (8). (b) Dependences r / rhex  f (ex ) for IV in cyclohexane
(1), THF (2), DCM (3), and ACN (4). (c) Dependence 1 / r (max
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absorption spectrum of IV in hexane: (a) curve 9; (b) 5, and (d) 4.

The analysis of the experimental dependence 1 / r (max
abs )  f (1 /  ) (Figure 3-3c) revealed
good agreement with a theoretical linear function:[67]

1 1    kT  1

 
r r0  r0  V  
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,

(iv)

which is indicative of the weak dependence of the fundamental anisotropy r0 on the solvent
properties and nearly constant effective rotational molecular volume V in all of the investigated
organic solvents. This means that the effective size of the solvate cages in different solvents are
sufficiently close and correspond to V  5000 Å3.
The photochemical stability of probe IV was investigated by an absorption method[71] in
the investigated organic solvents and aqueous media, except for ACN, in which a relatively low
solubility of IV was observed. Corresponding values of the photobleaching quantum yields,  Ph
are presented in Table 3-1. A high level of photostability (  Ph ~ (3 - 7)10-6) was observed for
IV in all investigated solvents except for electron-accepting DCM and aqueous media. Polar

DCM exhibits specific photochemical interaction with fluorene derivatives,[72, 73] resulting in a
dramatic decrease in their photostability (by ca. one order of magnitude) and efficient formation
of nonfluorescent photoproducts in the visible region. The estimations of the photochemical
stability of IV were performed under one-photon excitation conditions, since reactions from the
first exited state are nearly independent of the type of excitation (one- or two-photon) for typical
fluorene derivatives in organic solvents.[71-73] It should be mentioned that the observed level of
photostability of probe IV is one of the highest among known fluorescent probes used in
bioimaging applications.
3.3.2 2PA properties of IV and bioimaging
The efficiency of two-photon processes of IV was investigated in cyclohexane, DMSO,
and aqueous solution by a relative 2PF method,[54] with the corresponding broad range 2PA
spectra presented in Figure 3-4. The symmetrical probe IV exhibited one well defined 2PA band
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at  ex  680-720 nm with maxima cross sections  2PA ~ 800-900 GM and weak dependence on
solvent polarity. The spectral position of this band corresponded to the shoulder at  ex  340-360
nm in the excitation anisotropy spectrum of IV (Figure 3-3a, curve 1) and could not be extracted
from the linear absorption spectrum (curve 9). Dramatic decrease in the 2PA efficiency in the
main one-photon allowed absorption band is typical, consistent with the relatively symmetrical
structure of IV. Regardless of the decrease in 2PA efficiency, the values of  2PA and  2actPA
remain sufficiently high (~ 50-500 GM) in the main tuning range of Ti:sapphire laser, which is
the most convenient excitation source for bioimaging applications. In aqueous solution (95 wt%
water and 5 wt% DMSO) probe IV exhibited decreased 2PA efficiency in the main two-photon
allowed absorption band relative to pure DMSO, and nearly the same values of  2PA in the
spectral range  ex  750 nm.
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Figure 3-4 2PA spectra of IV in cyclohexane (1), DMSO (2), and aqueous solution (95 wt% water and 5
wt% DMSO) (3). Normalized one-photon absorption spectrum of IV in cyclohexane (4).
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The hydrophobic character of probe IV made it challenging to attempt delivering the dye
directly in a solution that was compatible to the solubility of the cell media. This made it an
ideal candidate for encapsulating this dye in a poloxomer micelle. The poloxomer of choice was
Pluronic® F-127, an FDA approved triblock copolymer that consists of a propylene oxide
portion flanked by two ethylene oxide chains. Pluronic® F-127 has been used in drug delivery
applications to enhance the solubility of hydrophobic substances such as anticancer drugs.[45,
46] Pluronic micelles are known to be uptaken by MDCK cells by means of clathrin-mediated
endocytosis when present above critical micelle concentration (CMC).[47]

Probe IV was

encapsulated in Pluronic® F-127, with the purpose of it being endocytosed, and subsequently
tracked through the vesicle maturation process.
HCT 116 cells were incubated for 3 h in Pluronic® F-127 encapsulated probe IV. A
series of 0.1, 1, 10, 25, and 50 µM solutions of the micelle-encapsulated probe in culture media
was prepared. These samples were coincubated with 75 nM of Lysotracker™ Red (Invitrogen)
for colocalization studies to determine whether the micelle-encapsulated probe reached the
lysosomes. After fixation, the one-photon fluorescence images exhibited good agreement
between the Lysotracker™ Red (Figure 3-5b) and the Pluronic® F-127 encapsulated 2PA probe
IV (Figure 3-5c), as shown by the overlay of micrographs of these two channels (Figure 3-5d).

The excellent colocalization agreement was further confirmed by determining the colocalization
coefficient ( 0.91).[51]
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Figure 3-5 Confocal fluorescence images of HCT 116 cells incubated with probe IV encapsulated in
Pluronic® F-127 (25 M, 3 h) and Lysotracker Red (100 nM, 3 h). (a) differential interference contrast
(DIC) image; (b) one-photon fluorescence image showing Lysotracker™ Red; (c) probe IV encapsulated
in Pluronic® F-127 micelles, and (d) colocalization (overlay of b and c).

Two-photon fluorescence microscopy (2PFM) images of fixed HCT 116 cells incubated
with probe IV encapsulated in Pluronic® F-127(50 M, 3 h ) were collected on a modified
Olympus Fluoview FV300 microscope system coupled to a tunable Coherent Mira 900F
Ti:sapphire, 76 MHz, modelocked, 200 fs laser tuned to 700 nm (Figure 3-6c). The 2PFM
image, Figure 3-6c, revealed remarkable contrast when compared to one-photon fluorescence
image (Figure 3-6b), and revealing the potential that this probe-micelle formulation has for
following the endocytotic process by 2PFM.
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Figure 3-6 One-and two-photon fluorescence micrographs of HCT 116 cells incubated with probe IV
encapsulated in Pluronic® F-127 (50 M, 3 h). (a) DIC image; (b) one-photon fluorescence and (c) 3D
reconstruction from overlaid 2PFM images, 76 MHz, 200 fs laser, 700 nm, 60x objective (NA= 1.35,
Olympus).

3.3.3 ESA superfluorescence and lasing properties
The ESA spectra of IV (Figure 3-7) were obtained in the region of its fluorescence (420700 nm) in order to estimate potential superfluorescence and lasing abilities of this new probe in
organic media with different polarity and in aqueous solution. Deduced from the data in Figure
3-7, potential amplification (i.e. negative values of ESA) was obtained only in nonpolar media
(hexane, cyclohexane) in the fluorescence region of IV. In the aqueous mixture, the ESA
spectrum was completely positive (Figure 3-7d) and the existence of small negative regions in
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ESA spectrum of IV in DMSO (Figure 3-7c) was not sufficient to reach real amplification.
Therefore, superfluorescence and lasing properties of IV were investigated in nonpolar media,
such as hexane, cyclohexane, and polystyrene films.
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Figure 3-7 Normalized absorption (1), fluorescence (2), and ESA (3) spectra of IV in hexane (a),
cyclohexane (b), DMSO (c), and aqueous solution (95 wt% water and 5 wt% DMSO) (d).

Efficient superfluorescence and lasing effects under longitudinal pumping at 355 nm
were observed for IV in hexane and cyclohexane solutions placed in 10 mm regular
spectrofluorometric cuvettes. The corresponding fluorescence and amplified stimulated emission
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spectra are presented in Figure 3-8. The lasing spectra of IV (curves 1) are characterized by
spectral width ~ 8-10 nm (FWHM), which are typical for organic dyes in a nondispersive
resonator (consisting of the exit uncoated surfaces of the cuvette).[74] Under the experimental
conditions, a low resonator quality facilitated simultaneous observation of superfluorescence
phenomenon in the pumping direction, which was not completely suppressed by resonator’s
oscillation.
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Figure 3-8 Lasing (1), superfluorescence (2), and fluorescence (3) spectra of IV in hexane (a) and
cyclohexane (b) under 355 nm longitudinal pumping in 10 mm quartz cuvettes.

Polystyrene samples with small thickness (< 100 m) were used in order to check
superfluorescence potential of IV in the case of small length amplification, which may have
application in bioimaging if the probe were contained within a hydrophobic medium (such as the
micelles above). The superfluorescence spectra of IV in the polystyrene films with different
thicknesses are presented in Figure 3-9. According to these spectra, even for a 5 m polymeric
layer, some degree of amplification was observed for IV. This suggests that sufficiently high
amplification per unit length in nonpolar medium can be utilized for increasing of the spectral
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brightness of fluorescence labels. These amplification conditions potentially can be realized
inside specially constructed micelles with high concentrated solution of IV and high reflective
envelope. The development of such fluorescent labels for bioimaging with increased spectral
brightness is currently ongoing in our lab.
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Figure 3-9 Fluorescence (1) and superfluorescence (2) spectra of IV in polystyrene films with
thicknesses: 85 m (a), 50 m (b), 15 m (c), and 5 m (d) under 355 nm longitudinal pumping.
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3.4 Experimental Section

3.4.1 Synthesis of probe IV
2-(5-Bromothiophen-2-yl)benzothiazole 1 and 2,7-dibromo-9,9-didecyl-9H-fluorene 6
were prepared as described in the literature.[27, 28] Microwave-facilitated reactions were carried
out under N2 in a CEM Discover microwave reactor in 10 mL closed vessels, programmed at a
maximum temperature of 130 °C, maximum pressure of 100 psi, and maximum power of 100
Watts. All reagents and solvents were used as received from commercial suppliers unless
otherwise noted. 1H and

13

C NMR spectra were recorded in CDCl3 on a Varian NMR

spectrometer at 500 and 125 MHz, respectively. Elemental analyses were performed by Atlantic
Microlab, Inc.
Synthesis of 4-(5-(benzothiazol-2-yl)thiophen-2-yl)-2-methylbut-3-yn-2-ol (7): 2-(5-

Bromothiophen-2-yl)benzothiazole 2 (200 mg, 0.67 mmol), 2-methyl-3-butyn-2-ol (170 mg, 2.02
mmol), Pd(PPh3)2Cl2 (19 mg, 0.027 mmol) and CuI (5 mg, 0.027 mmol) were dissolved in a 1:4
mixture of Et3N:toluene (5 mL). The mixture was either heated under reflux for 12 h or
irradiated by microwave for 2 min, at which time it was determined by TLC that the reaction was
completed. The mixture was filtered through a celite plug, and purified by column
chromatography using hexanes:EtOAc (1:1) to yield 192 mg (96%) of pale yellow solid by either
method; m.p. 164-165 °C. 1H NMR (500 MHz, CDCl3) δ8.02 (d, J=8.04Hz, 1H, Ph-H), 7.85 (d,
J=7.87Hz, 1H, Ph-H), 7.50 (d, J=3.95 Hz, 1H, Thy-H), 7.47 (m, 1H, Ph-H), 7.38 (m, 1H, Ph-H),
7.18 (d, J=3.95 Hz, 1H, Thy-H), 2.11 (s, 1H, -OH), 1.64 (s, 6H, CH3).

13

C NMR (125 MHz,

CDCl3) δ 160.4, 153.6, 137.9, 134.7, 132.9, 128.3, 126.4, 125.4, 123.1, 121.5, 121.4, 100.2, 75.2,
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65.8, 31.3.Anal. Calcd for C16H13NOS2: C, 64.18; H, 4.38; N, 4.68. Found: C, 64.10; H, 4.33; N,
4.64.
Synthesis of 2-(5-ethynylthiophen-2-yl)benzothiazole (8): 4-(5-(Benzothiazol-2-

yl)thiophen-2-yl)-2-methylbut-3-yn-2-ol 7 (300 mg, 1.0 mmol) and KOH (300 mg, 5.3 mmol)
were heated either under reflux for 2 h or under microwave irradiation for 8 min. The mixture
was filtered, and purified by column chromatography using hexanes to yield 180 mg (75%) by
conventional heating or 236 mg (98%) via microwave of pale yellow solid; m.p. 117-118 °C. 1H
NMR (500 MHz, CDCl3) δ 8.03 (d, J=8.21Hz, 1H, Ph-H), 7.86 (d, J=8.21Hz, 1H, Ph-H), 7.51
(d, J=3.94 Hz, 1H, Thy-H), 7.48 (m, 1H, Ph-H), 7.39 (m, 1H, Ph-H), 7.28 (d, J=3.94 Hz, 1H,
Thy-H), 3.50 (s, 1H, C≡C-H). 13C NMR (125 MHz, CDCl3) δ60.2, 153.6, 138.5, 134.8, 133.9,
133.7, 127.8, 126.5, 125.4, 123.2, 121.6, 84.0, 76.5. Anal. Calcd for C13H7NS2: C, 64.70; H,
2.92; N, 5.80. Found: C, 64.64; H, 2.91; N, 5.75.
Synthesis

of

2,2'-(5,5'-(9,9-didecyl-9H-fluorene-2,7-diyl)bis(ethyne-2,1-

diyl)bis(thiophene-5,2-diyl))dibenzothiazole (IV):[52] 2,7-Bibromo-9,9-didecyl-9H-fluorene 6

(300 mg, 0.50 mmol), 2-(5-ethynylthiophen-2-yl)benzothiazole 8 (263 mg, 1.09 mmol),
Pd(PPh3)2Cl2 (30 mg, 0.04 mmol), and CuI (8 mg, 0.04 mmol) were dissolved in a 1:4 mixture of
Et3N:toluene (5 mL). The mixture was heated under reflux for 12 h or by microwave for 1 h. The
mixture was filtered through a celite plug and purified by column chromatography using
hexanes:EtOAc (10:1) to yield 252 mg (55%) of a yellow solid by conventional heating and 298
mg (65%) when microwave irradiation was used; m.p. 74.0-75.5 °C.1H NMR (500 MHz, CDCl3)
δ 8.04 (dd, J=8.09 Hz, J=0.54 Hz, 2H, Ph-H), 7.87 (dd, J=8.04 Hz, J=0.53 Hz, 2H, Ph-H), 7.70
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(d, J=7.83 Hz,2H, Ph-H), 7.57 (d, J=3.89 Hz, 1H, Thy-H), 7.55 (m, 2H, Ph-H), 7.53 (m, 2H, PhH), 7.49 (m, 2H, Ph-H), 7.39 (m, 2H, Ph-H), 7.31 (d, J=3.89 Hz, 1H, Thy-H), 2.00 (m, 4H, CH2),
1.15 (m, 28H, CH2), 0.84 (t, J=6.96 Hz, 6H, CH3), 0.61 (m, 4H, CH2).

13

C NMR (125 MHz,

CDCl3) δ 160.5, 153.7, 151.3, 141.1, 138.0, 134.7, 132.6, 130.8, 128.4, 127.1, 126.6, 125.9,
125.5, 123.1, 121.5, 121.3, 120.2, 97.0, 82.9, 55.4, 40.3, 31.9, 30.0, 29.6, 29.5, 29.3, 29.3, 23.8,
22.7, 14.1. Anal. Calcd for C59H60N2S4: C, 76.58; H, 6.54; N, 3.03. Found: C, 76.79; H, 6.75; N,
2.79.
3.4.2 Linear photophysical characterization and one-photon bioimaging
The steady-state linear spectral data, fluorescence quantum yields, and lifetimes of 1 were
measured in hexane, cyclohexane, toluene, tetrahydrofuran (THF), dichloromethane (DCM),
dimethylsulfoxide (DMSO), acetonitrile (ACN), and an aqueous mixture (95 wt% water and 5
wt% DMSO) at room temperature. All solvents were of spectroscopic grade, received from
commercial sources, and used without further purification. One-photon absorption spectra of IV
were obtained with an Agilent 8453 UV–visible spectrophotometer using quartz cuvettes with
different path lengths (0.01, 0.1, 1.0 and 10 mm) for a broad range of molecular concentrations
10-2 M  C  10-6 M. The steady-state fluorescence and excitation anisotropy spectra were
measured with a PTI QuantaMaster spectrofluorimeter, in 10 mm spectrofluorometric quartz
cuvettes for low concentration solutions C  10-6 M. All experimentally registered fluorescence
spectra were corrected for the spectral responsivity of the PTI detection system. The excitation
anisotropy spectra of IV were obtained in the L-format configuration geometry,[67] with
extraction of pure solvent emission and scattered light. Fluorescence quantum yields,  , of IV
at low concentration were determined by a standard relative method with 9,10
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diphenylanthracene in cyclohexane as a reference compound.[67] The values of fluorescence
lifetimes of IV,  , were obtained with a time-correlated single photon counting system
PicoHarp 300 under linear polarized (oriented by the magic angle) femtosecond excitation, with
time resolution  80 ps. The values of  were obtained through the best tail fitting.
Epifluorescence one-photon fluorescence images were obtained using inverted
microscope (Olympus IX70) equipped with a QImaging cooled CCD (Model Retiga EXi) and
excitation mercury lamp 100 W and an Olympus IX81 DSU equipped with a Hammamatsu EMCCD C9100. In order to improve the fluorescence background-to-image ratios a customized
filter cube (Ex 377/50, DM 409, Em 460/50) was used for the one-photon fluorescence images.
The specifications of the filter cube were tailored to match the excitation and emission of IV.
3.4.3 Cell culture and incubation
HCT 116 cell were cultured in DMEM, supplemented with 10% FBS, and 1% penicillin,
1% streptomycin, at 37 °C, under 5% CO2 environment. N° 1 round 12 mm coverslips were
treated with poly-D-lysine, to improve cell adhesion, and washed (3x) with PBS buffer solution.
The treated cover slips were placed in 24-well plates and 80,000 cells/well were seeded and
incubated at the same conditions as indicated above until 75-85% confluency was reached on the
coverslips. From a 3.03 x 10-4 M stock solution of Pluronic 127 encapsulated probe IV, a series
of 0.1, 1, 10, 25, and 50 µM solutions in culture media were prepared, all containing 75 nM of
Lysotracker™ Red (Invitrogen). These solutions were used to incubate the cells for 3 h. The
dye solutions were extracted and the coverslipped cells were washed abundantly with PBS (4x).
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Cell fixing and mounting: Cells were fixed with 3.7% solution of paraformaldehyde in
pH=7.4 PBS buffer for 10 min. The fixing agent was extracted and washed (2x) with PBS. To
reduce autofluorescence, a fresh solution of NaBH4 (1 mg/mL) in pH=8 PBS buffer was used to
treat the fixed cells (2x). The coverslipped cells were then washed with buffer PBS (2x) and
mounted on microscope slides using Prolong Gold (Invitrogen) as mounting media.
3.4.4 Cell viability
Cell viability was assessed with CellTiter 96 AQ (Promega). HCT 116 cells were
seeded (5x103 cells/well) in a 96 well plate and incubated for 24 h in 90 L of DMEM
(Invitrogen) without phenol red, supplemented with 10% FBS (Atlanta Biologicals), and 1%
penicillin-streptomycin. The cells were incubated for an additional 24 h with 60, 50, 25, 10, and
1 M solutions of Pluronic K 127-encapsulated probe IV in FBS complemented (10%) culture
media.

Then 20 M of the CellTiter 96 AQ reagent was added into each well and

subsequently incubated for another 4 h, 37 °C, after which the respective absorbance values were
read on a SpectraMax M5 plate reader (Molecular Devices) at 490 nm to determine the relative
amount of formazan produced. [75] Cell viability % was calculated by the following expression:

Cell

viability(%) 

S
B
Abs490nm
 Abs490nm
x100%
B2
AbsC490nm  Abs490nm

(iii)

where Abss490nm is the absorbance of the cells at the different concentrations of micelle
encapsulated probe IV, AbsB490nm is the absorbance of a cell-free well containing only
encapsulated probe IV at the concentrations that were studied, AbsC490nm is the absorbance of
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cells incubated in media without any other component, and AbsB2490nm is the absorbance of a
cell-free well.
The photochemical decomposition quantum yields of IV,  Ph , were determined in
organic solvents and aqueous mixture by the absorption method,[71] based on precise
measurements of kinetic changes in the corresponding absorption spectra during one-photon UV
irradiation (405 nm diode laser with CW irradiance ~ 30 mW/cm2). In this case, the values of

 Ph can be expressed by the equation:
Ph 

[D( ,0)  D( ,t ir )] N A
t ir

10  ( )  I()   [110
3

D( ,t )

,

(v)

]dt

0

where D( , t ) , N A ,  ( ) , I ( ) and tir are the optical density, Avogadro’s number, extinction
coefficient, laser irradiance, and total irradiation time, respectively. A comprehensive description
of this methodology was described previously.[71]

3.4.5 Two-photon spectral and bioimaging measurements
2PA spectra of probe IV were measured over a broad spectral region in spectroscopic
grade cyclohexane, DMSO, and aqueous media using a typical 2PF method relative to
Rhodamine B in methanol as a standard.[53] The 2PF technique employed a PTI QuantaMaster
spectrofluorimeter coupled with a femtosecond Clark-MXR CPA-2010 laser that pumped an
optical parametric generator/amplifiers (TOPAS) with a 600-950 nm tuning range, pulse duration

 140 fs (FWHM), 1 kHz repetition rate, and pulse energies up to ~ 0.15 J. Two-photon
fluorescence measurements were performed in 10 mm fluorometric quartz cuvettes with dye
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concentrations ~ 10-5 M. The values of 2PA cross section,  2 PA , were determined by the
equation:[54]



S
2PA



R
2PA

F(t) S  CR  R   R  P(t) 2R

,
F(t) R  CS  S   S  P(t) 2S

(ii)

where  F (t ) ,  P(t ) , C , and  are the averaged fluorescence intensity, excitation power,
molecular concentration, and geometric factor, respectively. Subscripts S and R refer to the
sample and reference compound. The quadratic dependence of 2PF intensity on the excitation
power was determined for each excitation wavelength, ex , while special attention was paid to
verify the independence of the fluorescence quantum yield on ex .
Two-photon fluorescence imaging was performed on a modified Olympus Fluoview
FV300 laser scanning confocal microscopy system equipped with a broadband, tunable Coherent
Mira Ti:sapphire laser (200 fs pulse width, 76 MHz repetition rate), pumped by a 10 W Coherent
Verdi frequency doubled Nd:YAG laser. The laser was tuned and modelocked to 700 nm and
used as the two-photon excitation source. The two-photon induced fluorescence was collected
by a 60x microscope objective (UPLANSAPO 60x, N.A.=1.35 Olympus). A high transmittance
(>95%) short-pass filter (cutoff 685 nm, Semrock) was placed in front of the PMT detector
within the FV300 scanhead in order to filter off background radiation from the laser source (700
nm).
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3.4.6 ESA superfluorescence and lasing measurements
The ESA spectra of IV were obtained in hexane, cyclohexane, toluene, DMSO, ACN,
and aqueous mixtures using a pump-probe technique with a picosecond Nd:YAG laser (PL 2143
B Ekspla). The experimental setup is illustrated in Figure 3-10. A strong pump beam at  ex =
355 nm, with pulse duration,  P  35 ps, (FWHM), pulse energy, E P ≤ 20 J, and repetition
rate 10 Hz, was focused into a 1 mm cuvette with dye concentration C ~ 510-5 M, to a waist
radius  1.5 mm.

1064 nm
1

2

355 nm

2

3
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3

7
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Sample
Sample
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5
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Figure 3-10 Experimental setups for ESA, superfluorescence and lasing measurements: picosecond laser
(1); 100% reflection mirrors (2); beam splitters (3); delay line (4); focusing lens (L1 - 15 cm; L2 - 25 cm);
neutral density and color filters (5); water cell (6); silicon detectors (7); spectrometer (8).
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A weak pulse of white light continuum (WLC), generated by the main laser output (1064
nm) in a 10 cm path length quartz cuvette with de-ionized water,[76] served as the probe beam.
The probe and pump beams were linearly polarized in the vertical direction and spatially
overlapped inside the sample. A small delay, ~ 80 ps, was introduced between pump and probe
pulses to avoid undesirable interaction. ESA spectra were determined with a Ocean Optics USB2000 spectrometer. The suprefluorescence and lasing spectra of IV were measured in hexane,
cyclohexane, and polystyrene matrices with dye concentration C ~ 510-3 - 510-5 M, under
longitudinal pumping at 355 nm (see Fig. 3-10, left channel) with pulse energy E P ≤ 20 J.
Liquid solutions of IV were placed in 0.1, 1.0, and 10 mm quartz cells. Dye-doped polymeric
samples were prepared by dissolving polystyrene in a cyclohexane solution containing IV,
followed by solvent evaporating over 24 h. The resulting polymer films (thickness < 100 m)
were placed between high optical quality quartz plates. The position of the samples inside the
focusing caustic (15 cm lens (Figure 3-10, L1)) was chosen to reach the highest efficiency of the
investigated effects. Measurements were performed with the same USB-2000 spectrometer. It
should be mentioned, that laser oscillation was observed in the direction perpendicular to the exit
surfaces of the quartz cells and served as a resonator, while superfluorescence emission occurred
in the direction of the pumping beam. This allowed us to separate the observed
superfluorescence and lasing phenomena.
3.5 Conclusions

The synthesis, linear photophysical, and nonlinear optical properties of a new fluorenebased probe IV with alkynyl bonds in the chromophore system were investigated in organic
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solvents and aqueous solution as a potential fluorescent label for two-photon bioimaging
applications. The shape and maximum extinction coefficients of the absorption spectra of IV
were independent of solvent polarity and no molecular aggregation effects were observed in the
range of concentrations up to 10-2 M. The fluorescence spectra of relatively symmetrical probe
IV were independent of  ex and exhibited noticeable solvatochromic behavior with substantial

changes in their shape. The values of the fluorescence quantum yields were sufficiently high in
organic media (   0.7-0.8) and independent of solvent polarity, while single-exponential
fluorescence decays were observed. In contrast, an aqueous solution of IV exhibited a dramatic
decrease in quantum yield accompanied by a bi-exponential decay in fluorescence emission.
The excitation anisotropy spectra revealed a complicated nature of the main long
wavelength absorption band of IV, consisting of more than one electronic transition. A weak
dependence of the fundamental anisotropy r0 on the solvent properties and nearly constant
effective rotational molecular volume V in all investigated organic solvents were shown.
Importantly, a high level of photostability (  Ph ~ (3 - 7)10-6) was observed for probe IV under
one-photon excitation conditions in several of the investigated solvents.
The 2PA spectra of IV were obtained under femtosecond excitation over a broad spectral
range (~ 640-920 nm) by a 2PF method. 2PA efficiency was characterized by the one well
defined two-photon allowed absorption band at 680-720 nm with corresponding maxima cross
sections  2PA  800-900 GM.
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The potential that probe IV has for 2PFM is based on its promising linear and nonlinear
photophysical properties, on the excellent contrast obtained with it both in one- and two-photon
fluorescence micrographs, and its selectivity to cell lysosomes of HCT 116 cells when
encapsulated in Pluronic® F-127. The simplicity of micelle encapsulation and straightforward
synthesis make it a probe that can be promptly prepared by the methods described. Furthermore,
2PFM facilitated the observation of cell features that were not entirely resolved in the
epifluorescence counterpart. This probe is certainly amenable to other applications in selective
imaging of tissue, where further functionalization of the Pluronic® 127 (with a peptide or an
antibody for example) could be employed for in vitro or in vivo tissue 2PFM imaging.
The ESA spectra revealed the possibility of potential light amplification in nonpolar
solutions of IV. Efficient lasing and superfluorescence effects were shown in hexane,
cyclohexane, and polystyrene films under the longitudinal pumping at 355 nm. A possibility for
amplification was shown for IV in thin polymer films up to 5 m thickness, which can be used
for the development of new fluorescent labels with increased spectral brightness. Based on these
results, the new probe IV, with its high fluorescence quantum yield, 2PA cross section,
photochemical stability, and efficient superfluorescence properties is a promising fluorescent
label for two-photon bioimaging applications.
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CHAPTER 4. SYNTHESIS AND BIOIMAGING OF NEW FLUORESCENT
TWO-PHOTON ABSORBING BIOCONJUGATES SELECTIVE
TOWARDS VASCULAR ENDOTHELIAL GROWTH FACTOR
RECEPTOR 2
4.1 Abstract

We report the synthesis and characterization of two amine reactive fluorescent dyes with
good two-photon absorption (2PA) properties. Bioconjugation of these dyes with a specific
antibody and bioimaging of these new materials demonstrated their selectivity towards the
vascular endothelial growth factor receptor 2 (VEGFR-2) in cells expressing this receptor and in
tissue. In addition, the concentration of dye required for incubation of these bioconjugates is in
the picomolar domain, and the fluorescence response obtained from one and 2PA imaging
demonstrated high quality and contrast at these low concentrations. We also describe how these
new systems offer several advantages compared to previously reported systems.
4.2 Introduction

The development of methodologies and materials to image cancer tumors is an area of
increasing interest in the chemical and biomedical communities. The conjugation of fluorescent
dyes with antibodies and peptides, used as targeting vectors, is a common strategy to image
tumors. In the interest of following tumor growth and drug efficacy, researchers have targeted
vasculature instead of the tumor itself to determine tumor size, morphology, and characteristics
by different technologies (immunohistochemistry, fluorescence microscopy, photoacoustic
microscopy, etc).[77-81]
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Angiogenesis is the process of forming new blood vessels to support tissue growth. This
fundamental physiological process promotes embryonic development, tissue repair, and fertility,
although it also promotes chronic inflammation, tumor growth, and tumor metastasis.[82]
Tumors in particular rely on angiogenesis for their continued growth. It has been demonstrated
that solid tumors will not grow larger than 2–3 mm in diameter in the absence of new blood
vessels and require angiogenesis to form metastases.[83]
Vascular endothelial growth factor (VEGF) is a protein that stimulates vascular
endothelial cell growth, survival, and proliferation. Thus, VEGF facilitates survival of existing
vessels, contributes to vascular abnormalities that may impede effective delivery of antitumor
compounds, and stimulates new vessel growth.[84-86]
The VEGF family consists of five members (VEGF-A, VEGF-B, VEGF-C, VEGF-D,
and placental growth factor), which show different affinities for one of the three VEGF tyrosine
kinase receptors (VEGFR-1, VEGFR-2 and VEGFR-3). VEGFR-1 and VEGFR-2 are expressed
in vascular endothelial cells. Moreover, there is evidence that VEGFR-2 is the major mediator of
VEGF-driven responses in endothelial cells and it has been considered to be crucial in
angiogenic processes.[86]
In 2005, Backer and coworkers reported the use of a boronated polyamidoamine
dendrimer able to target selectively vasculature by means of a VEGF containing bioconjugate
that directed the dendrimer to a specific receptor (VEGFR). The incorporation of a near infrared
(NIR) Cy5 dye was employed to track the bioconjugate. The targeting of tumor vasculature
endothelial cells, rather than the tumor itself, was achieved since endothelial cells in tumor
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neurovasculature express a significantly greater number of VEGFR-2 when compared to
quiescent endothelial cells.[87] More recent work has demonstrated the use of VEGF
bioconjugates containing NIR fluorescent dyes to study the possible expression of VEGFRs in
bladder inflammation.[88]
The use of 2PA absorbing fluorophores offers several advantages over their one-photon
NIR counterparts. In the nonlinear absorption process the fluorescence emission is proportional
to the square of the intensity of the incident light providing the system with numerous intrinsic
advantages for instance deeper penetration, more confined excitation areas, less scattering and
minimal photodamage outside of the focal point.[31]
The scientific community has access to a wealth of efficient 1PA fluorescent dyes with
emissions that range from the UV to the IR and that are commercially available. However, there
is a need to develop new dyes with high fluorescence quantum yields and 2PA cross sections that
meet the high photostability demands that two-photon fluorescence microscopy (2PFM)
imposes. We have previously described a strategy to create 2PA amine reactive probes that can
be conjugated to proteins or antibodies.[8, 34] In this work, we introduce the synthesis and
characterization of two new fluorescent amine reactive dyes based on a fluorenyl core. With
these probes, VEGFR-2 antibody bioconjugates (anti-VEGFR-2) were prepared to selectively
bind the VEGFR-2 in cells that overexpress this specific receptor. In this approach, the
integration of an antibody to the VEGFR-2, instead of the VEGF itself, as a targeting strategy
was achieved. Further studies including the incorporation of VEGF with a similar fluorophores
will be done in the future and compared with the current results.
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The fluorophore design was based on a small series of efficient 2PA dyes that were
recently reported.[52] The architecture of the fluorophores involved a fluorenyl core flanked by a
triple bond- thiophene bridge (π) that led to an electron withdrawing group on one side (A). On
the other, the fluorenyl core was tethered to the anti-VEGFR-2 that served as a donor (D). This
resulted in systems that have a D-π-A dipolar structure.
4.3 Results and Discussion

4.3.1 Synthesis of new fluorescent probes and preparation of bioconjugates
The synthesis of the 2PA amine reactive probes 16 and 20 was achieved in short reaction
times and high yields by using microwave-assisted synthesis, as illustrated in Scheme 4-1 and
Scheme 4-2, respectively. Briefly, fluorene derivative 13 was coupled to previously reported
intermediates 2 and 8 either by Stille or Sonogashira coupling to yield nitro derivatives 14 and
18. These nitro derivatives were reduced to the respective amine intermediates 15 and 19.[19]
Transformation of these amines into the corresponding isothiocyanates 16 and 20 was performed
by a method reported previously by our group. [8, 34, 35]
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Scheme 4-1

Scheme 4-2
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In order to better understand the scope and properties of these probes, conjugation with nbutylamine was performed to generate model compounds 17 and 21 that would closely resemble
the optical properties of the bioconjugates. Once obtained, amine reactive probes and models
were chemically and photophysically characterized.
2PA isothiocyanates 16 and 20 were conjugated to anti-VEGFR-2 for 2 hours at room
temperature in a molar proportion 10:1 dye: protein. Purification was achieved by using a
commercially available, Sephadex packed, GPC column.

4.3.1 Photophysical properties
Photophysical characterization was performed for amine reactive probes 16 and 20 and
model compounds 17 and 21. Absorption and emission spectra of these compounds were
collected at room temperature using DMSO solutions of the compounds at concentrations of
approximately 10-6 M and are shown in Figure 4-1.
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Figure 4-1 Normalized absorption (left) and fluorescence (right) spectra of compounds 16, 17, 20 and 21
in DMSO. Absorption and emission spectra were collected at room temperature using DMSO solutions
with optical density of ~0.1 (approximately 10-6 M) without degassing the solutions. Emission was
collected by exciting samples at their λabsmax value.
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Table 4-1 reveals that there are intense absorption maxima for amine reactive probes and
model compounds located between 390-400 nm, whereas there was a red shift in the emission
maxima when the dyes were conjugated to n-butylamine. In addition, a larger Stokes shift was
observed for the more conjugated model compound 21.
Table 4-1 Photophysical characterization of compounds 16, 17, 20 and 21 in DMSO.

1

Compound

λabsmax, nm

λemmax, nm

Φ

εmax 10-3,
M-1.cm-1

τ, ns

16

3971

4691

0.800.05

61

0.95

17

4001

5831

1.000.05

53

2.00

20

3911

4661

0.700.05

60

0.85

21

3911

5801

0.200.05

54

0.79

Fluorescence quantum yield measured relative to 9,10-diphenylanthracene in cyclohexane.
In our previous studies, we observed that the presence of isothiocyanate groups in the

fluorene system plays an important role by quenching the fluorescence of the dye, possibly by
inducing intersystem crossing and allowing the molecule to relax by other pathways rather than
by fluorescence, but the fluorescence seems to be restored (switch on) upon conjugation.[8, 34]
Interestingly, in the case of these new dyes, this effect was not observed. Although there was not
fluorescence quenching because of the presence of the SCN group, for the first dye 16, the
quantum yield increased upon conjugation, as expected. However, for the more conjugated dye
20, there was a significant decrease in the fluorescence quantum yield after conjugation with n-

butylamine. (Table 4-1). This important result suggests that luminescent properties cannot be
predicted based only on similarities between structures.
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Lifetimes for these series of compounds were also measured in DMSO at concentrations
of approximately 10-6 M, as shown in Table 4-1. A difference of 1.2 ns was found between the
fluorescence lifetime of models 17 and 21. Even though they have similar fluorescence maxima,
with this difference in lifetime it should be possible to distinguish between bioconjugates
containing these dyes and different antibodies or vectors by fluorescence lifetime imaging
microscopy (FLIM).
Anisotropy of samples were measured under one-photon excitation in poly-THF at
concentrations of approximately 10-6 M; and two-photon absorption (2PA) cross section of
model compounds were determined by the fluorescence method using DMSO solutions in
concentrations of ca. 10-5 M. Rhodamine B in methanol was employed as a standard.[53]
(Figure 4-2) Given that the selection rules are not the same for one or two photon excitation, it is
not expected that the one-photon and two-photon absorption spectra look the same. Both
compounds have a significant 2PA cross section value within the measured range (700-940 nm).
Anisotropy spectra exhibited a constant value at wavelengths where the maxima of linear
absorption were located, corresponding to the first electronic transition S0  S1 (one-photon
allowed, two-photon forbidden transition); in this region, there is a decrease in the two-photon
cross section value. Anisotropy begins to decrease below 350 nm, reaching a minimum at around
325 nm leading to a second “plateau”; this corresponds to the second electronic transition S0 
Sn, which is two-photon allowed according the symmetry selection rules, thus, a high value of
cross section is obtained at this excitation wavelength.
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Figure 4-2 Normalized absorption (dash lines), two-photon cross section (symbols and lines) and
anisotropy (solid lines) of model compounds 17 (black) and 21 (blue).

Another maximum in the 2PA spectra was observed at around 820 nm for both model
compounds. This transition correlated nicely to that responsible for the shoulder located at
around 410 nm in the linear absorption spectrum. These dyes can be excited by 2PA at
wavelengths as long as 850-900 nm and the fluorescence emission peaks at 580 nm extends ±
190 nm; these dyes have great versatility because they can be efficiently excited by a wide range
of wavelengths and their emission is in the far red to NIR range.
After bioconjugation of isothiocyanates with the selected antibody and purification by gel
permeation chromatography, fractions containing the bioconjugates were analyzed by UV-vis
spectrometry.

Figure 4-3 shows the absorption spectrum of isothiocyanate 20 (red) and

biconjugate B2 (green). The concentration of the protein in the bioconjugate was determined to
be around 50 μM and the degree of labeling (DOL) was found to be 2. The concentration of the
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dye in the purified solution was estimated to be around 0.4 μM by using the extinction
coefficient of model compounds. Preparation of bioconjugates following this method was
performed more than once to evaluate the reproducibility of the method; repeated preparation of
B1 and B2 generated these same results consistently.
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Figure 4-3 Normalized absorption of isothiocyanate 20 (red, solid line) and bioconjugate B2 (green,
dash-dot-dot line).

4.3.2 Cell imaging
To study the scope of the new bioconjugates, probes B1 and B2 were incubated with
porcine aortic endothelial (PAE-KDR) cells that express VEGFR-2, as it is known that this
receptor is found in higher concentrations when angiogenesis is occurring. Preliminary studies
demonstrated that fluorescence images obtained with B2 were superior to those obtained with
B1; although the latter has a higher quantum yield, but its lower cross section at 700 nm, where

the imaging was performed, resulted in lower contrast images (not shown). Thus, due to the
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excellent preliminary results obtained with B2, this bioconjugate was used for the subsequent
experiments.

PAE-KDR cells were incubated with a commercially available fluorescent

bioconjugate containing fluorescein isothiocyanate and a monoclonal VEGFR-2 antibody, as a
positive control, and our bioconjugate B2. After 2 h of incubation, epifluorescence micrographs
of the incubated cells revealed a high degree of colocalization between the two probes (Figure 44).

Figure 4-4 Epifluorescence Micrographs PAE-KDR: A) DIC 60x; B) monoclonal VEGR-2 antibody
FITC; C) polyclonal VEGR-2 antibody Fluor B2; D) Overlay of B and C.

To examine the selectivity of bioconjugate B2 towards the VEGFR-2, porcine aortic
endothelial (PAE) cells that do not overexpress the receptor were used as a negative control. In
this way, B2 was incubated with porcine aortic endothelial (PAE) cells (control) and porcine
aortic endothelial cells that express VEGFR-2 (PAE-KDR). Efficient epifluorescence and 2PA
micrographs of PAE-KDR cells were obtained even at the very low concentrations that were
employed (0.4 μM) (Figure 4-5).
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Figure 4-5 One- and two-photon fluorescence micrographs of PAE-KDR (porcine aortic endothelial cells
expressing VEGFR-2) incubated with bioconjugate B2 (≈0.4 μM, 2 h). A) DIC, B) One-photon
fluorescence, C) 3D reconstruction from overlaid 2PFM images, 76 MHz, femtosecond laser 700 nm, 60x
objective (NA= 1.35, Olympus). Scale: 50 μm grid.

Porcine aortic endothelial (PAE) cells that do not express the receptor incubated under
similar conditions (same concentration of B2, same incubation time, temperature, etc)
demonstrated drastically different results; very little, nonspecific fluorescence was observed in
the respective micrographs (Figure 4-6). Fluorescence observed only in those cells that express
the receptor suggests that the antibody provides the desired selectivity to the probe. Moreover,
the higher resolution resulting from the nonlinearity of the two-photon absorption process is
evidenced in Figure 4-5 when images obtained by one photon excitation (B) are compared to
images obtained by two-photon excitation (C).
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Figure 4-6 One- and two-photon fluorescence micrographs of PAE (porcine aortic endothelial cells)
incubated with bioconjugate B2 (≈0.4 μM, 2 h). A) DIC, B) One-photon fluorescence, C) 3D
reconstruction from overlaid 2PFM images, 76 MHz, femtosecond laser 700 nm, 60x objective (NA=
1.35, Olympus). Scale: 50 μm grid.

4.3.3 Tissue imaging
Preliminary tissue staining with bioconjugate B2 was performed on mouse embryonic
tissue sections. Mouse embryo (2 days) tissue sections (200 μm) were incubated with
bioconjugate B2 and epifluorescence micrographs revealed vasculature specificity within the
tissue (Figure 4-7 D). Negative control of a neighboring tissue section only showed what
appeared to be autofluorescence of white blood cells (as proven by H&E staining), but no vessels
were seen (Figure 4-7 B).
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Figure 4-7 Brightfield of mouse embryo negative control (A) and polyclonal VEGR-2 antibody fluorene
bioconjugate B2 (C). Epifluorescence of negative control (B) and polyclonal VEGR-2 antibody fluorene
bioconjugate B2 (D).

Furthermore, 2PFM of this same tissue section (Figure 4-8) indicate that this system is
truly promising for imaging nascent micro vessels in tissue by this nonlinear technique. The
penetration and reduced scattering that is characteristic of 2PFM will more than likely be
successful in intratumor 2PFM of vasculature in live mice models. Work is currently underway
in our lab for introducing this dye in Lewis Lung Carcinoma explants in mice and measuring
microvessel density in these tumors ex vivo and through a dorsal skinfold chamber (in vivo).[78,

89]
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Figure 4-8 Two-photon upconverted fluorescence polyclonal VEGR-2 antibody fluorene bioconjugate
B2. Excitation 700 nm (20 mW).

4.4 Experimental Section

4.4.1 Materials and methods
Key intermediates 13, 2 and 8 were prepared as described in the literature.[34, 52] All the
reactions were carried out under N2. Microwave assisted procedures were carried out in a CEM
Discover unit microwave in 10 mL closed vessels, temperature, pressure and power were
programmed at a maximum value, depending on the reaction. All other reagents and solvents
were used as received from commercial suppliers. 1H and

13

C NMR spectra were recorded in

CDCl3 on a Varian NMR spectrometer at 500 and 125 MHz, respectively. Mass analyses (APCI,
atmospheric pressure chemical ionization) were performed at University of Florida.

The

analyses were carried out on a Finnigan LCQ - Quadrupole Ion Trap (Thermo Finnigan, San
Jose, CA).
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4.4.2 Synthetic procedures and characterization
Synthesis of 2-(5-(9,9-bis(2-(2-ethoxyethoxy)ethyl)-7-nitro-9H-fluoren-2-yl)thiophen2-yl)benzothiazole (14): In a 10 mL vessel, under nitrogen, 9,9-bis(2-(2-ethoxyethoxy)ethyl)-2-

iodo-7-nitro-9H-fluorene

13

(200

mg,

0.335

mmol),

2-(5-(tributylstannyl)thiophen-2-

yl)benzothiazole 2 (207 mg, 0.408 mmol) and Pd(PPh3)2Cl2 (6 mg, 0.008 mmol) were dissolved
in toluene (2 mL). The mixture was heated in the microwave for 25 min, at 130 oC, 150 psi and
150W, filtered through a celite plug, and purified by column chromatography using as a solvent
a mixture of hexane:ethyl acetate (2:1) to yield 216 mg (98%) of a light orange solid. m.p. 75.776.5 oC. 1H NMR (500 MHz, CDCl3) δ 8.26-8.34 (m, 2H, Ph-H), 8.06 (d, J=8.06 Hz, 1H, Ph-H),
7.89 (d, J=8.06 Hz, 1H, Ph-H), 7.73-7.84 (m, 4H, Ph-H), 7.69 (d, J=3.93Hz, 1H, Thy-H), 7.497.52 (m, 1H, Ph-H), 7.48 (d, J=3.93Hz, 1H, Thy-H), 7.38-7.42 (m, 1H, Ph-H), 3.34-3.40 (m, 4H,
CH2), 3.27-3.31 (m, 4H, CH2), 3.15-3.22 (m, 4H, CH2), 2.79-2.93 (m, 4H, CH2), 2.45-2.56 (m,
4H, CH2), 1.10 (t, J=6.98 Hz, 6H, CH3).

13

C NMR (125 MHz, CDCl3) δ 161.1, 153.9, 152.1,

151.2, 147.7, 147.5, 146.3, 138.6, 137.0, 135.0, 134.8, 129.7, 126.8, 126.0, 125.6, 124.8, 123.9,
123.2, 122.2, 121.7, 121.0, 120.2, 119.3, 70.4, 69.8, 67.1, 66.8, 52.5, 39.6, 15.2. MS (APCI) m/z
calcd [M+H]+ 659.2244, found 659.2256.
Synthesis of 7-(5-(benzothiazol-2-yl)thiophen-2-yl)-9,9-bis(2-(2-ethoxyethoxy)ethyl)9H-fluoren-2-amine (15): In a 10 mL vessel, under nitrogen, 2-(5-(9,9-bis(2-(2-

ethoxyethoxy)ethyl)-7-nitro-9H-fluoren-2-yl)thiophen-2-yl)benzothiazole 14 (300 mg, 0.45
mmol) and 10% Pd/C (30 mg) were dissolved in a 1:1 mixture of

THF:EtOH (4 mL).

NH2NH2.2H2O (300 mg, 6.0 mmol) was added to the mixture dropwise at room temperature, and
then heated in the microwave to 110 oC, 100 W and 100 psi for 30 min. The mixture was filtered
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though a silica plug with ethyl acetate, and after removing the solvent under reduced pressure,
the material was purified by column chromatography using as a solvent ethyl acetate to yield 280
mg (97%) of a dark yellow solid. m.p. 120.8-121.4 oC. 1H NMR (500 MHz, CDCl3) δ 8.04 (d,

J=7.88 Hz, 1H, Ph-H), 7.86 (d, J=7.88 Hz, 1H, Ph-H), 7.59-7.67 (m, 3H, Ph-H Thy-H), 7.55 (d,
J=7.69 Hz, 1H, Ph-H), 7.45-7.50 (m, 2H, Ph-H), 7.34-7.40 (m, 2H, Ph-H, Thy-H), 6.75 (d,
J=7.99Hz, 1H, Ph-H), 6.68 (dd, J=7.99Hz, J=1.92Hz, 1H, Ph-H), 3.38-3.44 (m, 4H, CH2), 3.333.37 (m, 4H, CH2), 3.21-3.26 (m, 4H, CH2), 2.77-2.86 (m, 4H, CH2), 2.31-2.46 (m, 4H, CH2),
1.13 (t, J=7.05 Hz, 6H, CH3). 13C NMR (125 MHz, CDCl3) δ 161.3, 153.8, 151.1, 149.0, 148.8,
146.7, 141.6, 135.3, 134.6, 130.8, 130.7, 129.6, 129.6, 125.4, 125.1, 123.3, 122.8, 121.46, 121.1,
120.1, 119.0, 114.5, 109.8, 70.1, 69.7, 67.0, 66.6, 50.9, 39.9, 15.1. MS (APCI) m/z calcd
[M+H]+ 629.2502, found 629.2508.
Synthesis of 2-(5-(9,9-bis(2-(2-ethoxyethoxy)ethyl)-7-isothiocyanato-9H-fluoren-2yl)thiophen-2-yl)benzothiazole (16): In a two neck round bottom flask and under nitrogen, a

solution of 7-(5-(benzothiazol-2-yl)thiophen-2-yl)-9,9-bis(2-(2-ethoxyethoxy)ethyl)-9H-fluoren2-amine 15 (250 mg, 0.398 mmol) in chloroform (2 mL) was combined with an aqueous solution
of CaCO3 (103 mg, 1.03 mmol) in an ice bath. Thiophosgene (0.042 mL, 0.44 mmol) was added
to the vial dropwise while stirring the mixture and the reaction proceeded for 4 hours. After
completion, a 10% HCl solution was added until the gas formation ceased. The mixture was
poured into water, extracted with methylene chloride, dried over magnesium sulfate and purified
by column chromatography using as a solvent a mixture of hexane:ethyl acetate (2:1) to yield
200 mg (74%) of a light orange solid. m.p. 103.2-104.0 oC. 1H NMR (500 MHz, CDCl3) δ 8.04
(d, J=8.10 Hz, 1H, Ph-H), 7.86 (d, J=8.10 Hz, 1H, Ph-H), 7.70-7.73 (m, 1H, Ph-H), 7.61-7.68
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(m, 4H, Ph-H, Thy-H), 7.46-7.50 (m, 1H, Ph-H), 7.41 (d, 1H, J=4.10 Hz, Thy-H), 7.34-7.39 (m,
1H, Ph-H), 7.32 (d, J=1.68 Hz, 1H, Ph-H), 7.21 (dd, J=7.97 Hz, J=1.68 Hz, 1H, Ph-H), 3.363.42 (m, 4H, CH2), 3.30-3.35 (m, 4H, CH2), 3.18-3.23 (m, 4H, CH2), 2.78-2.91 (m, 4H, CH2),
2.38-2.47 (m, 4H, CH2), 1.12 (t, J=7.11 Hz, 6H, CH3).

13

C NMR (125 MHz, CDCl3) δ 161.0

153.7 151.1 150.3 148.0 139.6 139.0 136.2 135.4 134.7 133.1 130.2 129.6 129.5 124.2 122.9
121.5 121.4 121.1 120.92 120.85 120.7 120.6 120.4 70.1 69.6 66.9 66.6 51.8 39.6 15.1. MS
(APCI) m/z calcd [M+H]+ 671.2066, found 671.2068. UV-vis (DMSO) λmax 397 nm.
Synthesis

of

1-(7-(5-(benzothiazol-2-yl)thiophen-2-yl)-9,9-bis(2-(2-

ethoxyethoxy)ethyl)-9H-fluoren-2-yl)-3-butylthiourea (17): In a small vial under nitrogen, a

mixture of 2-(5-(9,9-bis(2-(2-ethoxyethoxy)ethyl)-7-isothiocyanato-9H-fluoren-2-yl)thiophen-2yl)benzothiazole 16 (56 mg, 0.083 mmol), and n-butylamine (0.074 mL, 1.0 mmol) at room
temperature was stirred for 1 hour. The remaining amine was removed under vacuum and the
residue was purified by column chromatography with hexane:ethyl acetate (1:1) to yield 50 mg
(80%) of a bright yellow solid. m.p. 67.0-68.0 oC. 1H NMR (500 MHz, CDCl3) δ 8.04 (d, J=8.13
Hz, 1H, Ph-H), 7.84-7.94 (m, 2H, Ph-H, N-H), 7.67-7.73 (m, 4H, Ph-H), 7.66 (d, J=4.01, 1H,
Thy-H), 7.47-7.52 (m, 1H, Ph-H), 7.42 (d, 1H, J=4.01 Hz, Thy-H), 7.35-7.40 (m, 1H, Ph-H),
7.32 (d, J=1.46 Hz, 1H, Ph-H), 7.21 (d, J=7.74 Hz, 1H, Ph-H), 6.34-6.39 (m, 1H, N-H), 3.623.69 (m, 2H, CH2), 3.32-3.41 (m, 4H, CH2), 3.24-3.30 (m, 4H, CH2), 3.12-3.21 (m, 4H, CH2),
2.78-2.98 (m, 4H, CH2), 2.36-2.44 (m, 4H, CH2), 1.57-1.65 (m, 2H, CH2), 1.35-1.43 (m, 2H,
CH2), 1.10 (t, J=6.96 Hz, 6H, CH3), 0.95 (t, J=7.55 Hz, 3H, CH3). 13C NMR (125 MHz, CDCl3)
δ 180.6 161.1 153.72 173.71 150.1 148.1 140.1 138.3 136.1 134.68 134.67 132.8 129.5 123.8
122.9 121.5 121.4 120.63 120.61 120.60 120.48 120.47 120.0 70.0 69.6 67.1 66.5 51.9 39.6 31.0
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20.2 15.1 15.0 13.9 MS (APCI) m/z calcd [M+H]+ 744.2958, found 744.2952. UV-vis (DMSO)
λmax 400 nm.
Preparation of bioconjugate B1: A mixture containing 100 μL of antibody (1 mg/mL)

and 100 μL of NaHCO3 (1 M) was combined with a fresh solution of isothiocyanate 16 in
DMSO in a proportion 1:10 molar protein:dye and incubated for 2 hours in the dark at room
temperature. The biconjugate was purified by using disposable PD-10 desalting columns from
GE equilibrated and eluted with PBS buffer 7.0 (Invitrogen). Fractions containing the
bioconjugate were identified using a spectrophotometer by monitoring bands at 280 nm and 400
nm. The degree of labeling was determined to be 1.8.
Synthesis

of

2-(5-((9,9-bis(2-(2-ethoxyethoxy)ethyl)-7-nitro-9H-fluoren-2-

yl)ethynyl)thiophen-2-yl)benzothiazole (18): In a 10 mL vessel, under nitrogen, 9,9-bis(2-(2-

ethoxyethoxy)ethyl)-2-iodo-7-nitro-9H-fluorene

13

(413

mg,

0.725

mmol),

2-(5-

ethynylthiophen-2-yl)benzothiazole 8 (175 mg, 0.725 mmol), Pd(PPh3)2Cl2 (21 mg, 0.03 mmol),
CuI (5.7 mg, 0.03 mmol), were dissolved in a 1:4 mixture of Et3N:toluene (3 mL). The mixture
was heated in the microwave for 1h, at 130 oC, 150 psi and 150W, filtered through a celite plug,
and purified by column chromatography using as a solvent a mixture of hexane:ethyl acetate
(2:1) to yield 505 mg (74%) of a light orange solid. m.p. 105.0-106.5 oC. 1H NMR (500 MHz,
CDCl3) δ 8.33 (d, J=2.00 Hz, 1H, Ph-H), 8.26 (dd, J=8.36 Hz, J=2.00 Hz, 1H, Ph-H), 8.02 (d,

J=7.95 Hz, 1H, Ph-H), 7.85 (d, J=7.95 Hz, 1H, Ph-H), 7.73-7.79 (m, 2H, Ph-H, Thy-H), 7.667.68 (m, 1H, Ph-H), 7.54-7.60 (m, 2H, Ph-H, Thy-H), 7.46-7.50 (m, 1H, Ph-H), 7.36-7.40 (m,
1H, Ph-H), 7.31 (d, J=3.92 Hz, 1H, Thy-H), 3.35-7.42 (m, 4H, CH2), 3.27-3.31 (m, 4H, CH2),
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3.15-3.21 (m, 4H, CH2), 2.80-2.93 (m, 4H, CH2), 2.43-2.54 (m, 4H, CH2), 1.12 (t, J=6.85 Hz,
6H, CH3). 13C NMR (125 MHz, CDCl3) δ 160.5, 153.8, 151.1, 147.5, 146.0, 138.8, 138.6, 134.9,
133.3, 133.1, 128.6, 128.5, 126.9, 126.7, 126.6, 123.4, 123.3, 121.7, 121.4, 119.2, 119.1, 96.0,
84.2, 70.3, 69.7, 66.9, 66.7, 52.3, 39.4, 15.2. MS (APCI) m/z calcd [M+H]+ 683.2244, found
683.2231.
Synthesis

of

7-((5-(benzothiazol-2-yl)thiophen-2-yl)ethynyl)-9,9-bis(2-(2-

ethoxyethoxy)ethyl)-9H-fluoren-2-amine (19): In a 10 mL vessel, under nitrogen, 2-(5-((9,9-

bis(2-(2-ethoxyethoxy)ethyl)-7-nitro-9H-fluoren-2-yl)ethynyl)thiophen-2-yl)benzothiazole

18

(250 mg, 0.366 mmol) and 10% Pd/C (25 mg) were dissolved in a 1:1 mixture of THF:EtOH (4
mL). NH2NH2.2H2O (220 mg, 4.4 mmol) was added to the mixture dropwise at room
temperature, and then heated in the microwave to 110 oC, 100 W and 100 psi for 30 min. The
mixture was filtered though a silica plug with ethyl acetate, and after removing the solvent under
reduced pressure, the material was purified by column chromatography using as a solvent a
mixture of hexane:ethyl acetate (1:3) to yield 200 mg (84%) of a light orange solid. m.p. 110-111
o

C. 1H NMR (500 MHz, CDCl3) δ 8.03 (d, J=8.09 Hz, 1H, Ph-H), 7.84 (d, J=8.09 Hz, 1H, Ph-

H), 7.52-7.57 (m, 2H, Ph-H, Thy-H), 7.43-7.52 (m, 4H, Ph-H), 7.35-7.39 (m, 1H, Ph-H), 7.28 (d,

J=4.09 Hz, 1H, Thy-H), 6.71-6.74 (m, 1H, Ph-H), 6.64-6.68 (m, 1H, Ph-H), 3.79 (s, 2H, NH2),
3.39-3.46 (m, 4H, CH2), 3.32-3.39 (m, 4H, CH2), 3.20-3.26 (m, 4H, CH2), 2.74-2.85 (m, 4H,
CH2), 2.29-2.44 (m, 4H, CH2), 1.15 (t, J=7.02 Hz, 6H, CH3).

13

C NMR (125 MHz, CDCl3) δ

160.6, 153.7, 151.3, 148.1, 147.1, 142.0, 137.7, 134.7, 133.0, 131.8, 130.6, 128.1, 127.4, 125.6,
125.5, 122.9, 121.7, 120.8 118.9, 118.0 115.1 113.9 110.2, 97.2 82.2 70.1 69.7 67.0 66.7 50.9
39.9 15.4 MS (APCI) m/z calcd [M+H]+ 653.2502, found 653.2510.
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Synthesis of 2-(5-((9,9-bis(2-(2-ethoxyethoxy)ethyl)-7-isothiocyanato-9H-fluoren-2yl)ethynyl)thiophen-2-yl)benzothiazole (20): In a two neck round bottom flask and under

nitrogen,

a

solution

of

7-((5-(benzothiazol-2-yl)thiophen-2-yl)ethynyl)-9,9-bis(2-(2-

ethoxyethoxy)ethyl)-9H-fluoren-2-amine 19 (178 mg, 0.273 mmol) in chloroform (2 mL) was
combined with an aqueous solution of CaCO3 (80 mg, 0.80 mmol) in an ice bath. Thiophosgene
(0.026 mL, 0.34 mmol) was added to the vial dropwise while stirring the mixture and the
reaction proceeded for 4 hours. After completion, a 10% HCl solution was added until the gas
formation ceased. The mixture was poured into water, extracted with methylene chloride, dried
over magnesium sulfate and purified by column chromatography using as a solvent a mixture of
hexane:ethyl acetate (2:1) to yield 170 mg (90%) of a bright yellow solid. m.p. 86-88 oC. 1H
NMR (500 MHz, CDCl3) δ 8.05 (d, J=7.97 Hz, 1H, Ph-H), 7.87 (d, J=7.97 Hz, 1H, Ph-H), 7.637.67 (m, 2H, Ph-H), 7.53-7.61 (m, 3H, Ph-H Thy-H), 7.47-7.52 (m, 1H, Ph-H), 7.37-7.42 (m,
1H, Ph-H), 7.30-7.33 (m, 2H, Ph-H), 7.21-7.24 (m, 1H, Ph-H), 3.39-3.45 (m, 4H, CH2), 3.303.35 (m, 4H, CH2), 3.18-3.23 (m, 4H, CH2), 2.75-2.85 (m, 4H, CH2), 2.34-2.45 (m, 4H, CH2),
1.15 (t, J=7.01 Hz, 6H, CH3). 13C NMR (125 MHz, CDCl3) δ 160.4, 153.7, 151.2, 149.4, 139.8,
138.8, 138.1, 135.5, 134.7, 132.3, 130.5, 126.8, 126.5, 126.2, 124.9, 123.1, 123.0, 121.60,
121.58, 121.4, 121.2, 120.9, 120.6, 120.0, 96.4, 83.3, 70.1, 69.6, 67.3, 66.6, 51.7, 39.5, 15.1. MS
(APCI) m/z calcd [M+H]+ 695.2067, found 695.2076. UV-vis (DMSO) λmax 391 nm.
Synthesis

of

1-(7-((5-(benzothiazol-2-yl)thiophen-2-yl)ethynyl)-9,9-bis(2-(2-

ethoxyethoxy)ethyl)-9H-fluoren-2-yl)-3-butylthiourea (21): In a small vial under nitrogen, a

mixture

of

2-(5-((9,9-bis(2-(2-ethoxyethoxy)ethyl)-7-isothiocyanato-9H-fluoren-2-

yl)ethynyl)thiophen-2-yl)benzothiazole 20 (58 mg, 0.083 mmol), and n-butylamine (0.074 mL,
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1.0 mmol) at room temperature was stirred for 1 hour. The remaining amine was removed under
vacuum and the residue was recrystallized from hexane:ethyl acetate (9:1) to yield 48 mg (75%)
of a light yellow solid. m.p. 118.5-119.5 oC. 1H NMR (500 MHz, CDCl3) δ 8.05 (d, J=8.07 Hz,
1H, Ph-H), 7.88 (d, J=8.07 Hz, 1H, Ph-H), 7.78 (s, 1H, N-H), 7.66-7.73 (m, 2H, Ph-H), 7.547.62 (m, 3H, Ph-H Thy-H), 7.48-7.53 (m, 1H, Ph-H), 7.37-7.43 (m, 1H, Ph-H), 7.29-7.33 (m,
2H, Ph-H, Thy-H), 7.15-7.22 (m, 1H, Ph-H), 6.36 (s,1H, N-H), 3.62-3.71 (m, 2H, CH2), 3.343.43 (m, 4H, CH2), 3.22-3.32 (m, 4H, CH2), 3.10-3.22 (m, 4H, CH2), 2.74-2.97 (m, 4H, CH2),
2.34-2.45 (m, 4H, CH2), 1.61 (quintuplet, J=7.05 Hz, 2H, CH2), 1.40 (sextuplet, J=7.05 Hz, 2H,
CH2), 1.13 (t, J=7.05 Hz, 6H, CH3), 0.96 (t, J=7.83 Hz, 6H, CH3). 13C NMR (125 MHz, CDCl3)
δ 180.6, 168.1, 160.4, 153.7, 149.2, 140.4, 138.2, 138.1, 134.7, 132.9, 132.7, 128.5, 128.4, 126.9,
126.5, 126.5, 126.3, 123.1, 121.54, 121.5, 121.4, 121.3, 120.2, 120.1, 96.4, 83.1, 70.0, 69.6, 67.1,
66.5, 51.9, 45.5, 39.6, 30.9, 20.2, 15.1, 13.8. MS (APCI) m/z calcd [M+H]+ 768.2958, found
768.3010. UV-vis (DMSO) λmax 391 nm.
Preparation of bioconjugate B2: A mixture containing 100 μL of antibody (1 mg/mL)

and 100 μL of NaHCO3 (1 M) was combined with a fresh solution of isothiocyanate 20 in
DMSO in a proportion 1:10 molar protein:dye and incubated for 2 hours in the dark at room
temperature. The bioconjugate was purified by using disposable PD-10 desalting columns from
GE equilibrated and eluted with PBS buffer 7.0 (Invitrogen). Fractions containing the
bioconjugate were identified using a spectrophotometer by monitoring bands at 280 nm and 391
nm. The degree of labeling was determined to be 2.
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4.4.3 Measurements
Spectra of amine reactive probes and model compounds were collected from DMSO
solutions with concentrations in the order of 10-6 M at room temperature using 1 cm quartz
cuvettes. Absorption spectra were recorded with an Agilent 8453 UV–visible spectrophotometer.
Steady-state fluorescence spectra were measured with a PTI Quantamaster spectrofluorimeter in
the photon counting regime of the PMT using an L-format configuration. The fluorescence
spectra were corrected for the spectral dependence of the PMT. Fluorescence quantum yields
were determined relative to 9, 10-diphenylanthracene in cyclohexane. Absorption spectra of
bioconjugates B1 and B2 were measured in PBS buffer using 1 mm quartz cuvettes.
Two-photon absorption spectra were measured by the two-photon fluorescence 2PF
method relative to Rhodamine B in methanol [53] using solutions with concentrations of
approximately 10-4 M in spectroscopic grade DMSO following the methodology previously
reported [52]

4.4.4 Cell culture and incubation
PAE (Porcine aortic endothelial) and PAE/KDR (commercially available Porcine aortic
endothelial expressing 2x105 VEGFR-2 per cell), were cultured in F-12 Nutrient mixture (Ham’s
medium, Invitrogen) containing 10% fetal bovine serum (FBS) (Atlanta Biologicals) and 1%
penicillin/ streptomycin, at 37 °C, under 5% CO2 environment. Monoclonal anti-human VEGFR2/KDR-Fluorescein isothiocyanate bioconjugate was obtained from R&D Systems and was used
as a positive control without further treatment.
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N° 1 round 12 mm coverslips were treated with poly-D-lysine, and washed (3x) with PBS
buffer solution. The treated cover slips were placed in 24-well plates and 60,000 cells/well were
seeded and incubated at the same conditions as indicated above until 75%-85% confluency was
reached on the coverslips.
For the positive control, PAE-KDR cells were incubated for 2 hours in a solution
containing 0.4 μM solution of bioconjugate B2 and the monoclonal antibody bioconjugate (25
μg/mL) in culture media. PAE (negative control) and PAE-KDR cells were incubated for 2
hours in a 0.4 μM solution of bioconjugate B2 in culture media. The dye solutions were
extracted and the coverslipped cells were washed abundantly with PBS (4x).
Cell fixing and mounting: Cells were fixed with 3.7% solution of paraformaldehyde in
pH=7.4 PBS buffer for 10 min. The fixing agent was extracted and washed (2x) with PBS. To
reduce autofluorescence, a fresh solution of NaBH4 (1 mg/mL) in pH=8 PBS buffer was used to
treat the fixed cells (2x). The coverslipped cells were then washed with buffer PBS (2x) and
mounted on microscope slides using Prolong Gold (Invitrogen) as a mounting media.

4.4.5 Tissue Immunoflurescence staining
2-day old mouse embryo sections were deparaffinized (60 °C for 5 min; then, xylene for
5 min) and rehydrated (EtOH 100%, 95% and 80% twice for 1 min each). Antigen retrieval was
performed in sodium citrate buffer solution (6 mM, in conventional microwave 95-100 °C, 10
min) and the tissue sections were allowed to cool for 20 min. Subsequently, tissue sections were
permeabilized with Triton X (0.1%, 10 m) and were incubated with bioconjugate B2 (0.4 μM, for
1.5 h). No dye was added to negative control.
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4.4.6 One-photon epifluorescence imaging
One-photon (conventional) fluorescence microscopy images were recorded on an
Olympus IX-81 microscope equipped with a Hamamatsu EM-CCD C9100 digital camera. Onephoton fluorescence images of the fixed cells were taken using a custom made filter cube
(Ex:377/50; DM: 409; Em:525/40) and a FITC filter cube (Ex:477/50; DM: 507; Em:536/40) for
bioconjugate B2 and FITC anti-VEGFR-2, respectively.

4.4.7 Two-photon upconverted fluorescence imaging
Two-photon fluorescence microscopy (2PFM) imaging was performed on a modified
Olympus Fluoview FV300 laser scanning microscopy system equipped with a broadband,
tunable Coherent Mira Ti:sapphire laser (200 fs pulse width, 76 MHz repetition rate), pumped by
a 10 W Coherent Verdi frequency doubled Nd:YAG laser. The Ti:sapphire laser, tuned 700 nm
and modelocked, was used as the two-photon excitation source.

Two-photon induced

fluorescence was collected by a 60x microscope objective (UPLANSAPO 60x, N.A.=1.35
Olympus). A high transmittance (>95%) short-pass filter (cutoff 685 nm, Semrock) was placed
in front of the PMT detector within the FV300 scanhead in order to filter off background
radiation from the laser source (700 nm).
4.5 Conclusions

We developed and synthesized new two-photon absorbing fluorescent amine reactive
probes and bioconjugates. Photophysical characterization was performed for amine reactive
probes, model compounds, and bioconjugates. The new probes demonstrated better
characteristics and optical properties than those observed for commercially available
bioconjugates. Successful imaging by one and two-photon excitation with the bioconjugate B2 in
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cells and tissue was performed, demonstrating that the new bioconjugates selectively bind
VEGFR-2 in cell culture and tissue sections.
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CHAPTER 5. FUTURE WORK
The development and use of 2PA fluorescent dyes that incorporate a polyclonal antibody to
specifically target the vascular endothelial growth factor receptor 2 (VEGFR-2) has been
successfully achieved in cells and mouse embryo tissue, as demonstrated in Chapter 4. Although
the obtained results proved that the system works satisfactorily, further efforts can be done in
order refine the method, improve even more the results, and ultimately, to take maximum
advantage of this technology. In this chapter we discuss how this system can be improved. In
addition, we comment on the areas where we envision that this system can be useful, as well as
further projects that can be completed using this kind of bioconjugates.
5.1 Additional Improvements to the System

The incorporation of a monoclonal antibody (mAb) rather than a polyclonal antibody as the
vector that will direct the fluorescent dye towards the desired receptor is a subject that must be
studied. Recent reports have demonstrated that in some cases, although more expensive, the use
of a monoclonal antibody rather than a polyclonal antibody, will result in a higher specificity of
the bioconjugate towards the receptor. For example, Bodor et al. developed a series of
monoclonal antibodies to study myocardial infarction or heart attack.

In their work they

compare their results with previous similar studies that used a polyclonal antibody,
demonstrating that in this case monoclonal antibodies give the desired response faster and more
selectively.[90]. On the other hand, studies have demonstrated that the use of monoclonal
antibodies instead of polyclonal antibodies not necessarily result in higher specificity; in fact, the
use of antibodies microarrays has been suggested and used as a technique to analyze antibody
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specificity, since the interactions between the protein and the antibodies cannot be deduced
easily.[91]
In our future studies, comparison between images obtained with the mAb with those obtained
using the polyclonal antibody will reveal if the nature of the antibody is a factor that could derive
in a better target resolution or more specific images in this particular case. To perform these
series of studies, a mAb selective to the VEGFR-2 must be conjugated with the 2PA fluorescent
dye. Specifically, the commercially available monoclonal antibody DC-101 can be used to
conjugate the dye following the procedure described in Chapter 4. Monoclonal antibodies DC101 and IMC-1C11, are currently used in cancer treatment since it is know that they block
VEGFR interactions in mice and humans, respectively, thus, inhibiting tumor growth. [92-94]
Upon completion of these studies, the reproducibility of the method must be proved by repetition
of the experiments. The use of monoclonal antibodies may lead not only to imaging of tumors
but to therapy, thus, in the future, procedures where VEGFR are blocked with specific antibodies
could be used for both imaging and treatment as it has been demonstrated that they result in
delayed growth of tumors.[92, 93] This is the most important and urgent modification that must
be implemented to the system in order to continue with further studies.
Another possible adaptation that the system could undergo would be based on the systematic
study of the variation of the degree of labeling (DOL) of the bioconjugate. In the presented work,
a DOL of 2 resulted in satisfactory images, but in further studies the quality of the results could
be correlated to the variation of the DOL. A low DOL could result in poor fluorescence, while
too high DOL could yield poor selectivity because of loss of functionality of the antibody and
decrease in the fluorescence due to self-quenching. [95-97]

98

Finally, despite the fact that the dye used to conjugate to the antibody demonstrated to have good
optical properties, a new design of the dye based on the structure of compound III (Chapter 1)
that incorporates the antibody on the 9 position of a fluorene rather than on the conjugated
system, could result in a bioconjugate with even better properties than those observed in our
model conjugates (Chapter 4).
5.2 Potential Future Projects

Based on the studies performed, the next expected step that involves the use of these
bioconjugates is clear: in vivo imaging of vasculature in mice. To perform these studies, the
bioconjugate will be injected into the vein tail of mice following reported and accepted
protocols. Briefly, Lewis Lung Carcinoma will be implanted in the dorsum of 6 week old
BALB/c mice. Bioconjugate will be injected in the tail vein several days after tumor
implantation. Animals will be sacrificed and sections of tumors removed, treated as necessary
and studied with the equipment for one and two-photon fluorescence microscopy described in
previous chapters. The same protocol can be used to perform in vivo imaging of live small
animals. In this case, animals will be anesthetized before imaging.[87] The deeper penetration
that can be achieved by 2PA excitation will be essential in these series of experiments.
Angiogenesis is an essential factor associated with microvascular density measurements. 3D
imaging of blood microvessels results fundamental in areas such as cancer research or heart
disease research since the microvessel density (MVD) has been correlated with VEGF; therefore,
MVD quantification has been used as a method to evaluate angiogenesis.[77, 80, 81, 98]
Nonetheless, high resolution imaging of MVD still remains a challenge. In 2000, Callagy and coworkers examined the relationship between VEGF, MVD and tumor stage in breast cancer. One
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of the conclusions of this work is that the measurement of MVD seems to be not very reliable
with current technologies available, indicating that accurate and reproducible methods for
evaluating angiogenesis through MVD measurements are required.[77]
Quantification of MVD results very important in heart disease research since an increase
in this density means an improvement in the condition of the patient after stroke. Microvascular
density might be studied also to not only allow visualization of all vessels, but also distinguish
those that are actually perfused.[98] Additionally, efficacy of antibody-based oncotherapy can
be followed with this methodology.[77] Moreover, microvascular density has been associated
with measurements of type and degree of tumors, and the prognosis of patients with these tumors
through immunohistopathology.[99]
Although immunohistochemistry, magnetic resonance imaging (MRI) combined with laser
scanning confocal microscopy, and photoacustic microscopy techniques have evolved to be used
to image subcutaneous MVD as well as to correlate vessel size with blood volume, the proposed
nonlinear fluorescent method (2FPM) provides high contrast, good penetration, and good
resolution, which are fundamental to obtain reliable qualitative and quantitative data of the
morphology and size of these microvessels in fixed tissue and ultimately in vivo. [77, 80, 81, 98,
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APENDIX A: 1H AND 13C NMR SPECTRA OF NEW MOLECULES IN
CHAPTER 1
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